BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Demetris A, Adams D, Bellamy C, Blakolmer K, Clouston A, Dhillon AP, Fung J, Gouw A, Gustafsson B, Haga H, Harrison D, Hart J, Hubscher S, Jaffe R, Khettry U, Lassman C, Lewin K, Martinez O, Nakazawa Y, Neil D, Pappo O, Parizhskaya M, Randhawa P, Rasoul-Rockenschaub S, Reinholt F, Reynes M, Robert M, Tsamandas A, Wanless I, Wiesner R, Wernerson A, Wrba F, Wyatt J, Yamabe H. Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology. 2000;31:792-799. [PMID: 10706577 DOI: 10.1002/hep.510310337] [Cited by in Crossref: 377] [Cited by in F6Publishing: 309] [Article Influence: 17.1] [Reference Citation Analysis]
Number Citing Articles
1 Hübscher SG. Central perivenulitis: a common and potentially important finding in late posttransplant liver biopsies. Liver Transpl 2008;14:596-600. [PMID: 18433067 DOI: 10.1002/lt.21451] [Cited by in Crossref: 43] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
2 Sebagh M, Samuel D. Place of the liver biopsy in liver transplantation. Journal of Hepatology 2004;41:897-901. [DOI: 10.1016/j.jhep.2004.10.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
3 Junge G, Tullius SG, Klitzing V, Schewior L, Pratschke J, Radke C, Neuhaus R, Neuhaus P. The influence of late acute rejection episodes on long-term graft outcome after liver transplantation. Transplant Proc 2005;37:1716-7. [PMID: 15919442 DOI: 10.1016/j.transproceed.2005.04.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
4 Lacaille F, Canioni D, Fournet JC, Revillon Y, Cezard JP, Goulet O. Centrilobular necrosis in children after combined liver and small bowel transplantation. Transplantation. 2002;73:252-257. [PMID: 11821740 DOI: 10.1097/00007890-200201270-00018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
5 Benden C, Dipchand AI, Danziger-isakov LA, Esquivel CO, Ringdén O, Wray J, Marks SD. Pediatric Transplantation : Ten years on. Pediatric Transplantation 2009;13:272-7. [DOI: 10.1111/j.1399-3046.2008.01096.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
6 Sundaram SS, Melin-Aldana H, Neighbors K, Alonso EM. Histologic characteristics of late cellular rejection, significance of centrilobular injury, and long-term outcome in pediatric liver transplant recipients. Liver Transpl 2006;12:58-64. [PMID: 16382471 DOI: 10.1002/lt.20661] [Cited by in Crossref: 40] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
7 Capron A, Lerut J, Latinne D, Rahier J, Haufroid V, Wallemacq P. Correlation of tacrolimus levels in peripheral blood mononuclear cells with histological staging of rejection after liver transplantation: preliminary results of a prospective study. Transpl Int. 2012;25:41-47. [PMID: 21981711 DOI: 10.1111/j.1432-2277.2011.01365.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 6.2] [Reference Citation Analysis]
8 Elens L, Capron A, Kerckhove VV, Lerut J, Mourad M, Lison D, Wallemacq P, Haufroid V. 1199G>A and 2677G>T/A polymorphisms of ABCB1 independently affect tacrolimus concentration in hepatic tissue after liver transplantation. Pharmacogenet Genomics 2007;17:873-83. [PMID: 17885626 DOI: 10.1097/FPC.0b013e3282e9a533] [Cited by in Crossref: 79] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
9 Gao Z. Seeking Beyond Rejection: An Update on the Differential Diagnosis and a Practical Approach to Liver Allograft Biopsy Interpretation. Advances in Anatomic Pathology 2009;16:97-117. [DOI: 10.1097/pap.0b013e31819946aa] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Tan HH, Fiel MI, del Rio Martin J, Schiano TD. Graft rejection occurring in post-liver transplant patients receiving cytotoxic chemotherapy: a case series. Liver Transpl 2009;15:634-9. [PMID: 19479807 DOI: 10.1002/lt.21727] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
11 Sebagh M, Samuel D, Antonini TM, Coilly A, Degli Esposti D, Roche B, Karam V, Dos Santos A, Duclos-vallée J, Roque-afonso A, Ballot E, Guettier C, Blandin F, Saliba F, Azoulay D. Twenty-year protocol liver biopsies: Invasive but useful for the management of liver recipients. Journal of Hepatology 2012;56:840-7. [DOI: 10.1016/j.jhep.2011.11.016] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
12 Sakamoto S, Kasahara M, Mizuta K, Kuroda T, Yagi T, Taguchi T, Inomata Y, Umeshita K, Uemoto S; for the Japanese Liver Transplantation Society. Nationwide survey of the outcomes of living donor liver transplantation for hepatoblastoma in Japan: LDLT for Hepatoblastoma in Japan. Liver Transpl 2014;20:333-46. [DOI: 10.1002/lt.23803] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
13 Demetris AJ; Banff Working Group. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology 2006;44:489-501. [DOI: 10.1002/hep.21280] [Cited by in Crossref: 256] [Cited by in F6Publishing: 194] [Article Influence: 16.0] [Reference Citation Analysis]
14 Benten D, Staufer K, Sterneck M. Orthotopic liver transplantation and what to do during follow-up: recommendations for the practitioner. Nat Clin Pract Gastroenterol Hepatol 2009;6:23-36. [PMID: 19029996 DOI: 10.1038/ncpgasthep1312] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
15 van den Heuvel MC, de Jong KP, van der Horst ML, Poppema S, Slooff MJ, Gouw AS. Impaired regeneration of biliary cells in human chronic liver allograft rejection. Special emphasis on the role of the finest branches of the biliary tree. Liver Transpl 2004;10:28-35. [PMID: 14755774 DOI: 10.1002/lt.20029] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
16 Gao LH, Zheng SS, Zhu YF, Wan YL, Wei GQ, Qian SK, Jiang WJ. A rat model of chronic allograft liver rejection. Transplant Proc 2005;37:2327-32. [PMID: 15964409 DOI: 10.1016/j.transproceed.2005.03.031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
17 Ito D, Akamatsu N, Togashi J, Kaneko J, Arita J, Hasegawa K, Sakamoto Y, Kokudo N. Behavior and clinical impact of ascites after living donor liver transplantation: risk factors associated with massive ascites: Behavior and clinical impact of ascites after living donor liver transplantation: risk factors associated with massive ascites. J Hepatobiliary Pancreat Sci 2016;23:688-96. [DOI: 10.1002/jhbp.390] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
18 Langrehr JM, Puhl G, Bahra M, Schmeding M, Spinelli A, Berg T, Schönemann C, Krenn V, Neuhaus P, Neumann UP. Influence of donor/recipient HLA-matching on outcome and recurrence of hepatitis C after liver transplantation. Liver Transpl. 2006;12:644-651. [PMID: 16555324 DOI: 10.1002/lt.20648] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
19 Castillo-Rama M, Sebagh M, Sasatomi E, Randhawa P, Isse K, Salgarkar AD, Ruppert K, Humar A, Demetris AJ. "Plasma cell hepatitis" in liver allografts: identification and characterization of an IgG4-rich cohort. Am J Transplant 2013;13:2966-77. [PMID: 24011021 DOI: 10.1111/ajt.12413] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
20 Demirhan B, Bilezikçi B, Haberal AN, Sevmiş Ş, Arat Z, Haberal M. Hepatic parenchymal changes and histologic eosinophilia as predictors of subsequent acute liver allograft rejection. Liver Transpl 2008;14:214-9. [DOI: 10.1002/lt.21360] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
21 Boyd A, Cain O, Chauhan A, Webb GJ. Medical liver biopsy: background, indications, procedure and histopathology. Frontline Gastroenterol 2020;11:40-7. [PMID: 31885839 DOI: 10.1136/flgastro-2018-101139] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
22 Wong SY, Levitsky J. Chronic rejection related to hepatitis B immunoglobulin discontinuation in a liver transplant recipient. Transpl Int. 2011;24:e104-e106. [PMID: 21902731 DOI: 10.1111/j.1432-2277.2011.01334.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
23 Cho JY, Suh K, Lee HW, Cho E, Yang SH, Cho YB, Yi N, Kim MA, Jang J, Lee KU. The clinical significance of early histological rejection with or without biochemical abnormality in adult living donor liver transplantation for hepatitis B virus related end stage liver disease. Transplant Int 2007;20:37-44. [DOI: 10.1111/j.1432-2277.2006.00384.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
24 Jain A, Mazariegos G, Pokharna R, Parizhskaya M, Smith A, Kashyap R, Fung JJ, Reyes J. Almost total absence of chronic rejection in primary pediatric liver transplantation under tacrolimus. Transplant Proc 2002;34:1968-9. [PMID: 12176649 DOI: 10.1016/s0041-1345(02)03143-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
25 Takahashi Y, Nishimoto Y, Matsuura T, Hayashida M, Tajiri T, Soejima Y, Taketomi A, Maehara Y, Taguchi T. Surgical complications after living donor liver transplantation in patients with biliary atresia: a relatively high incidence of portal vein complications. Pediatr Surg Int 2009;25:745-51. [DOI: 10.1007/s00383-009-2430-y] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
26 Desai M, Neuberger J. Chronic liver allograft dysfunction. Transplant Proc. 2009;41:773-776. [PMID: 19328977 DOI: 10.1016/j.transproceed.2009.01.038] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
27 Fairfield C, Penninga L, Powell J, Harrison EM, Wigmore SJ. Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients. Cochrane Database Syst Rev 2018;4:CD007606. [PMID: 29630730 DOI: 10.1002/14651858.CD007606.pub4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
28 Magee JC. Graft fibrosis in stable pediatric liver transplant recipients: What does it mean? Hepatology 2009;49:726-8. [DOI: 10.1002/hep.22864] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
29 Shetty S, Adams DH, Hubscher SG. Post-transplant liver biopsy and the immune response: lessons for the clinician. Expert Review of Clinical Immunology 2014;8:645-61. [DOI: 10.1586/eci.12.65] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
30 Venturi C, Sempoux C, Quinones JA, Bourdeaux C, Hoyos SP, Sokal E, Reding R. Dynamics of allograft fibrosis in pediatric liver transplantation. Am J Transplant. 2014;14:1648-1656. [PMID: 24934832 DOI: 10.1111/ajt.12740] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
31 Balan V, Ruppert K, Demetris AJ, Ledneva T, Duquesnoy RJ, Detre KM, Wei YL, Rakela J, Schafer DF, Roberts JP. Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Hepatology. 2008;48:878-888. [PMID: 18752327 DOI: 10.1002/hep.22435] [Cited by in Crossref: 69] [Cited by in F6Publishing: 50] [Article Influence: 4.9] [Reference Citation Analysis]
32 Barbier L, Garcia S, Cros J, Borentain P, Botta-Fridlund D, Paradis V, Le Treut YP, Hardwigsen J. Assessment of chronic rejection in liver graft recipients receiving immunosuppression with low-dose calcineurin inhibitors. J Hepatol. 2013;59:1223-1230. [PMID: 23933266 DOI: 10.1016/j.jhep.2013.07.032] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
33 Weber A. Role of Histopathology. In: Clavien P, Trotter JF, editors. Medical Care of the Liver Transplant Patient. Oxford: Wiley-Blackwell; 2012. pp. 332-44. [DOI: 10.1002/9781444398441.ch30] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
34 Demetris AJ, Eghtesad B, Marcos A, Ruppert K, Nalesnik MA, Randhawa P, Wu T, Krasinskas A, Fontes P, Cacciarelli T, Shakil AO, Murase N, Fung JJ, Starzl TE. Recurrent Hepatitis C in Liver Allografts: Prospective Assessment of Diagnostic Accuracy, Identification of Pitfalls, and Observations About Pathogenesis. The American Journal of Surgical Pathology 2004;28:658-69. [DOI: 10.1097/00000478-200405000-00015] [Cited by in Crossref: 80] [Cited by in F6Publishing: 55] [Article Influence: 4.4] [Reference Citation Analysis]
35 Stanca CM, Fiel MI, Kontorinis N, Agarwal K, Emre S, Schiano TD. Chronic ductopenic rejection in patients with recurrent hepatitis C virus treated with pegylated interferon alfa-2a and ribavirin. Transplantation. 2007;84:180-186. [PMID: 17667809 DOI: 10.1097/01.tp.0000269609.08495.45] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
36 Solez K, Racusen LC. The Banff classification revisited. Kidney International 2013;83:201-6. [DOI: 10.1038/ki.2012.395] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 7.2] [Reference Citation Analysis]
37 Kim R, Joung D, Lee S, Jeong I, Oh SH, Namgoong JM, Kim DY, Kim KM. Cytomegalovirus Infection under a Hybrid Strategy in Pediatric Liver Transplantation: A Single-Center Experience. Pediatr Gastroenterol Hepatol Nutr 2017;20:178-85. [PMID: 29026734 DOI: 10.5223/pghn.2017.20.3.178] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
38 Bramhall SR, Minford E, Gunson B, Buckels JA. Liver transplantation in the UK. World J Gastroenterol. 2001;7:602-611. [PMID: 11819840 DOI: 10.3748/wjg.7.602] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
39 Haga H, Egawa H, Shirase T, Miyagawa A, Sakurai T, Minamiguchi S, Yamabe H, Manabe T, Tanaka K. Periportal edema and necrosis as diagnostic histological features of early humoral rejection in ABO-incompatible liver transplantation. Liver Transpl. 2004;10:16-27. [PMID: 14755773 DOI: 10.1002/lt.20002] [Cited by in Crossref: 71] [Cited by in F6Publishing: 55] [Article Influence: 3.9] [Reference Citation Analysis]
40 Capron A, Lerut J, Verbaandert C, Mathys J, Ciccarelli O, Vanbinst R, Roggen F, De Reyck C, Lemaire J, Wallemacq PE. Validation of a Liquid Chromatography-Mass Spectrometric Assay for Tacrolimus in Liver Biopsies After Hepatic Transplantation: Correlation With Histopathologic Staging of Rejection. Therapeutic Drug Monitoring 2007;29:340-8. [DOI: 10.1097/ftd.0b013e31805c73f1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
41 Ünlü S, Lachmann N, Jara M, Ritschl PV, Wiering L, Eurich D, Denecke C, Biebl M, Chopra S, Gül-Klein S, Schöning W, Schmelzle M, Reinke P, Tacke F, Pratschke J, Öllinger R, Dziodzio T. Treatment of Anti-HLA Donor-Specific Antibodies Results in Increased Infectious Complications and Impairs Survival after Liver Transplantation. J Clin Med 2020;9:E3986. [PMID: 33317012 DOI: 10.3390/jcm9123986] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Sebagh M, Azoulay D, Roche B, Hoti E, Karam V, Teicher E, Bonhomme-Faivre L, Saliba F, Duclos-Vallée JC, Samuel D. Significance of isolated hepatic veno-occlusive disease/sinusoidal obstruction syndrome after liver transplantation. Liver Transpl 2011;17:798-808. [PMID: 21351239 DOI: 10.1002/lt.22282] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
43 van der Veer MAA, Nangrahary N, Hesselink DA, Erler NS, Metselaar HJ, van Gelder T, Darwish Murad S. High Intrapatient Variability in Tacrolimus Exposure Is Not Associated With Immune-mediated Graft Injury After Liver Transplantation. Transplantation 2019;103:2329-37. [PMID: 30801539 DOI: 10.1097/TP.0000000000002680] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
44 Ueda D, Yoshizawa A, Kaneshiro M, Hirata Y, Yagi S, Hata K, Okajima H, Egawa H, Uemoto S. Low Titers of Antidonor ABO Antibodies After ABO-Incompatible Living Donor Liver Transplantation: A Long-Term Follow-Up Study. Transplant Direct 2019;5:e420. [PMID: 30656218 DOI: 10.1097/TXD.0000000000000858] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
45 Lladó L, Fabregat J, Castellote J, Ramos E, Torras J, Serrano T, Figueras J, Rafecas A. Sirolimus-based rescue therapy after rejection in liver transplantation. Clin Transplant 2009;23:89-95. [PMID: 19200220 DOI: 10.1111/j.1399-0012.2008.00906.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
46 Egawa H, Nakanuma Y, Maehara Y, Uemoto S, Eguchi S, Sato Y, Shirabe K, Takatsuki M, Mori A, Yamamoto M, Tsubouchi H. Disease recurrence plays a minor role as a cause for retransplantation after living-donor liver transplantation for primary biliary cirrhosis: A multicenter study in Japan: Recurrence of pPBC after LT. Hepatol Res 2013;43:502-7. [DOI: 10.1111/j.1872-034x.2012.01108.x] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
47 Núñez-Martínez O, De la Cruz G, Salcedo M, Molina J, De Diego A, Ripoll C, Calleja J, Alvarez E, Clemente G. Liver transplantation for autoimmune hepatitis: fulminant versus chronic hepatitis presentation. Transplant Proc 2003;35:1857-8. [PMID: 12962824 DOI: 10.1016/s0041-1345(03)00591-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
48 Dogan N, Hüsing-Kabar A, Schmidt HH, Cicinnati VR, Beckebaum S, Kabar I. Acute allograft rejection in liver transplant recipients: Incidence, risk factors, treatment success, and impact on graft failure. J Int Med Res 2018;46:3979-90. [PMID: 29996675 DOI: 10.1177/0300060518785543] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
49 Kim JM, Ryu JH, Lee KW, Hong SK, Yang K, Choi GS, Kim YA, Lee JY, Yi NJ, Kwon CHD, Chu CW, Suh KS, Joh JW. Effect of CYP3A5 on the Once-Daily Tacrolimus Conversion in Stable Liver Transplant Patients. J Clin Med 2020;9:E2897. [PMID: 32911703 DOI: 10.3390/jcm9092897] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Kaneko J, Sugawara Y, Tamura S, Aoki T, Sakamoto Y, Hasegawa K, Yamashiki N, Kokudo N. De novo malignancies after adult-to-adult living-donor liver transplantation with a malignancy surveillance program: comparison with a Japanese population-based study. Transplantation. 2013;95:1142-1147. [PMID: 23572128 DOI: 10.1097/tp.0b013e318288ca83] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
51 Lunz JG 3rd, Contrucci S, Ruppert K, Murase N, Fung JJ, Starzl TE, Demetris AJ. Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs. Am J Pathol. 2001;158:1379-1390. [PMID: 11290556 DOI: 10.1016/s0002-9440(10)64089-8] [Cited by in Crossref: 88] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
52 Buyse S, Roque-Afonso AM, Vaghefi P, Gigou M, Dussaix E, Duclos-Vallée JC, Samuel D, Guettier C. Acute hepatitis with periportal confluent necrosis associated with human herpesvirus 6 infection in liver transplant patients. Am J Clin Pathol 2013;140:403-9. [PMID: 23955460 DOI: 10.1309/AJCP0FWI2XAHECBJ] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
53 Heidenhain C, Pratschke J, Puhl G, Neumann U, Pascher A, Veltzke-Schlieker W, Neuhaus P. Incidence of and risk factors for ischemic-type biliary lesions following orthotopic liver transplantation. Transpl Int. 2010;23:14-22. [PMID: 19691661 DOI: 10.1111/j.1432-2277.2009.00947.x] [Cited by in Crossref: 117] [Cited by in F6Publishing: 109] [Article Influence: 9.0] [Reference Citation Analysis]
54 Masuda S, Inui K. An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients. Pharmacol Ther. 2006;112:184-198. [PMID: 16759707 DOI: 10.1016/j.pharmthera.2006.04.006] [Cited by in Crossref: 146] [Cited by in F6Publishing: 114] [Article Influence: 9.1] [Reference Citation Analysis]
55 Demetris AJ. Distinguishing between recurrent primary sclerosing cholangitis and chronic rejection. Liver Transpl. 2006;12:S68-S72. [PMID: 17051552 DOI: 10.1002/lt.20947] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
56 Ramsay M. Role of microdialysis catheters in clinical decision making: Bench to bedside?: Editorial. Liver Transpl 2013;19:243-5. [DOI: 10.1002/lt.23602] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
57 Husain AN, Chang A, Ranganathan S. Diagnosis in Pediatric Transplant Biopsies. Surgical Pathology Clinics 2010;3:797-866. [DOI: 10.1016/j.path.2010.06.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
58 Selzner N, Guindi M, Renner EL, Berenguer M. Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients. Journal of Hepatology 2011;55:207-17. [DOI: 10.1016/j.jhep.2010.11.012] [Cited by in Crossref: 78] [Cited by in F6Publishing: 67] [Article Influence: 7.1] [Reference Citation Analysis]
59 Chen Y, Luo F, Luo S, Wu Z, Zhou J. The augmenter of liver regeneration protects the kidneys after orthotopic liver transplantation possibly by upregulating HIF-1α and O2-sensitive K+ channels. Surg Today 2011;41:382-9. [DOI: 10.1007/s00595-010-4282-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
60 Angelico R, Sensi B, Manzia TM, Tisone G, Grassi G, Signorello A, Milana M, Lenci I, Baiocchi L. Chronic rejection after liver transplantation: Opening the Pandora’s box. World J Gastroenterol 2021; 27(45): 7771-7783 [PMID: 34963740 DOI: 10.3748/wjg.v27.i45.7771] [Reference Citation Analysis]
61 Tateo M, Roque-Afonso AM, Antonini TM, Medja F, Lombes A, Jardel C, Teicher E, Sebagh M, Roche B, Castaing D. Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity. AIDS. 2009;23:1069-1076. [PMID: 19417577 DOI: 10.1097/qad.0b013e32832c2a37] [Cited by in Crossref: 37] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
62 Moeller J, Krukemeyer MG, Morawietz L, Schmeding M, Dankof A, Neumann U, Krenn V, Berek C. Molecular case report: IgVH analysis in acute humoral and cellular liver allograft rejection suggests a selected accumulation of effector B cells and plasma cells. Virchows Arch. 2005;446:325-332. [PMID: 15714338 DOI: 10.1007/s00428-004-1182-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
63 Bradley BA. Rejection and recipient age. Transpl Immunol. 2002;10:125-132. [PMID: 12216942 DOI: 10.1016/s0966-3274(02)00058-8] [Cited by in Crossref: 68] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
64 Sakashita H, Haga H, Ashihara E, Wen MC, Tsuji H, Miyagawa-Hayashino A, Egawa H, Takada Y, Maekawa T, Uemoto S, Manabe T. Significance of C4d staining in ABO-identical/compatible liver transplantation. Mod Pathol 2007;20:676-84. [PMID: 17431411 DOI: 10.1038/modpathol.3800784] [Cited by in Crossref: 71] [Cited by in F6Publishing: 52] [Article Influence: 4.7] [Reference Citation Analysis]
65 Sanz X, Pareja L, Rius A, Rodenas P, Abdón N, Gálvez J, Esteban L, Escribà JM, Borràs JM, Ribes J. Definition of a SNOMED CT pathology subset and microglossary, based on 1.17 million biological samples from the Catalan Pathology Registry. Journal of Biomedical Informatics 2018;78:167-76. [DOI: 10.1016/j.jbi.2017.11.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
66 Jin H, Dahmen U, Liu A, Huang H, Gu Y, Dirsch O. Prolonged Cold Ischemia Does Not Trigger Lethal Rejection or Accelerate the Acute Rejection in Two Allogeneic Rat Liver Transplantation Models. Journal of Surgical Research 2012;175:322-32. [DOI: 10.1016/j.jss.2011.03.078] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
67 Harimoto N, Ikegami T, Nakagawara H, Yamashita Y, Yoshizumi T, Uchiyama H, Soejima Y, Ikeda T, Shirabe K, Aishima S, Oda Y, Maehara Y. Chronic Immune-Mediated Reaction Syndrome as the Cause of Late Graft Mortality in Living-Donor Liver Transplantation for Primary Biliary Cirrhosis. Transplantation Proceedings 2014;46:1438-43. [DOI: 10.1016/j.transproceed.2014.02.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
68 Quaglia A, Duarte R, Patch D, Ngianga-Bakwin K, Dhillon AP. Histopathology of graft versus host disease of the liver. Histopathology 2007;50:727-38. [PMID: 17493237 DOI: 10.1111/j.1365-2559.2007.02679.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
69 Mccaughan GW, Shackel NA, Strasser SI, Dilworth P, Tang P; on The behalf of The Australian and New Zealand Liver Transplant Study Group. Minimal but significant improvement in survival for non-hepatitis C-related adult liver transplant patients beyond the one-year posttransplant mark. Liver Transpl 2010;16:130-7. [DOI: 10.1002/lt.21978] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
70 Schmeding M, Dankof A, Krenn V, Krukemeyer MG, Koch M, Spinelli A, Langrehr JM, Neumann UP, Neuhaus P. C4d in acute rejection after liver transplantation--a valuable tool in differential diagnosis to hepatitis C recurrence. Am J Transplant 2006;6:523-30. [PMID: 16468961 DOI: 10.1111/j.1600-6143.2005.01180.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 62] [Article Influence: 4.6] [Reference Citation Analysis]
71 Lovell MO, Speeg KV, Halff GA, Molina DK, Sharkey FE. Acute hepatic allograft rejection: A comparison of patients with and without centrilobular alterations during first rejection episode: Centrilobular Hepatic Allograft Rejection. Liver Transpl 2004;10:369-73. [DOI: 10.1002/lt.20094] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
72 Sood S, Testro AG. Immune monitoring post liver transplant. World J Transplant 2014; 4(1): 30-39 [PMID: 24669365 DOI: 10.5500/wjt.v4.i1.30] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
73 Couchonnal E, Rivet C, Ducreux S, Dumortier J, Bosch A, Boillot O, Collardeau-Frachon S, Dubois R, Hervieu V, André P, Scoazec JY, Lachaux A, Dubois V, Guillaud O. Deleterious impact of C3d-binding donor-specific anti-HLA antibodies after pediatric liver transplantation. Transpl Immunol 2017;45:8-14. [PMID: 28782692 DOI: 10.1016/j.trim.2017.08.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
74 Geramizadeh B, Motevalli D, Nikeghbalian S, Malek Hosseini SA. Histopathology of post-transplant liver biopsies, the first report from iran. Hepat Mon 2013;13:e9389. [PMID: 24032049 DOI: 10.5812/hepatmon.9389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
75 Schlegel A, Kron P, Graf R, Clavien PA, Dutkowski P. Hypothermic Oxygenated Perfusion (HOPE) downregulates the immune response in a rat model of liver transplantation. Ann Surg. 2014;260:931-937; discussion 937-938. [PMID: 25243553 DOI: 10.1097/sla.0000000000000941] [Cited by in Crossref: 62] [Cited by in F6Publishing: 28] [Article Influence: 8.9] [Reference Citation Analysis]
76 Kaneko J, Sugawara Y, Tamura S, Aoki T, Hasegawa K, Yamashiki N, Kokudo N. Long-term outcome of living donor liver transplantation for primary biliary cirrhosis. Transpl Int 2012;25:7-12. [PMID: 21923804 DOI: 10.1111/j.1432-2277.2011.01336.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
77 Ozeki M, Salah A, Aini W, Tamaki K, Haga H, Miyagawa-Hayashino A. Abnormal Localization of STK17A in Bile Canaliculi in Liver Allografts: An Early Sign of Chronic Rejection. PLoS One 2015;10:e0136381. [PMID: 26305096 DOI: 10.1371/journal.pone.0136381] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
78 Walter T, Dumortier J, Guillaud O, Hervieu V, Scoazec JY, Boillot O. Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: a retrospective analysis of 939 liver biopsies in a single center. Liver Transpl. 2007;13:294-301. [PMID: 17256784 DOI: 10.1002/lt.21000] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
79 Jazrawi SF, Zaman A, Muhammad Z, Rabkin JM, Corless CL, Olyaei A, Biggs A, Ham J, Chou S, Rosen HR. Tumor necrosis factor-alpha promoter polymorphisms and the risk of rejection after liver transplantation: a case control analysis of 210 donor-recipient pairs. Liver Transpl. 2003;9:377-382. [PMID: 12682890 DOI: 10.1053/jlts.2003.50064] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
80 Bouquegneau A, Loheac C, Aubert O, Bouatou Y, Viglietti D, Empana JP, Ulloa C, Murad MH, Legendre C, Glotz D, Jackson AM, Zeevi A, Schaub S, Taupin JL, Reed EF, Friedewald JJ, Tyan DB, Süsal C, Shapiro R, Woodle ES, Hidalgo LG, O'Leary J, Montgomery RA, Kobashigawa J, Jouven X, Jabre P, Lefaucheur C, Loupy A. Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis. PLoS Med 2018;15:e1002572. [PMID: 29799874 DOI: 10.1371/journal.pmed.1002572] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
81 Goddard S, Williams A, Morland C, Qin S, Gladue R, Hubscher SG, Adams DH. Differential expression of chemokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants. Transplantation. 2001;72:1957-1967. [PMID: 11773896 DOI: 10.1097/00007890-200112270-00016] [Cited by in Crossref: 102] [Cited by in F6Publishing: 93] [Article Influence: 5.1] [Reference Citation Analysis]
82 Mrzljak A, Skrtic A, Mikulic D, Gasparov S, Lovric E, Jadrijevic S, Poljak M, Kocman B. Liver re-transplantation in Croatia: change in graft histopathology. Transpl Int 2020;33:1553-4. [PMID: 32666541 DOI: 10.1111/tri.13701] [Reference Citation Analysis]
83 Kunugi S, Shimizu A, Ishii E, Kuwahara N, Arai T, Kataoka M, Masuda Y, Nagasaka S, Fukuda Y. The Pathological Characteristics of Acute Antibody-Mediated Rejection in DA-to-Lewis Rat Orthotopic Liver Transplantation. Transplantation Proceedings 2011;43:2737-40. [DOI: 10.1016/j.transproceed.2011.04.024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
84 Hann A, Osei-Bordom DC, Neil DAH, Ronca V, Warner S, Perera MTPR. The Human Immune Response to Cadaveric and Living Donor Liver Allografts. Front Immunol 2020;11:1227. [PMID: 32655558 DOI: 10.3389/fimmu.2020.01227] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
85 Tisone G, Orlando G, Cardillo A, Palmieri G, Manzia TM, Baiocchi L, Lionetti R, Anselmo A, Toti L, Angelico M. Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. J Hepatol. 2006;44:702-709. [PMID: 16473433 DOI: 10.1016/j.jhep.2005.11.047] [Cited by in Crossref: 125] [Cited by in F6Publishing: 114] [Article Influence: 7.8] [Reference Citation Analysis]
86 Krasinskas AM, Demetris AJ, Poterucha JJ, Abraham SC. The prevalence and natural history of untreated isolated central perivenulitis in adult allograft livers. Liver Transpl 2008;14:625-32. [DOI: 10.1002/lt.21404] [Cited by in Crossref: 47] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
87 Samonakis DN, Triantos CK, Thalheimer U, Quaglia A, Leandro G, Teixeira R, Papatheodoridis GV, Sabin CA, Rolando N, Davies S. Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation. Liver Transpl. 2005;11:386-395. [PMID: 15776454 DOI: 10.1002/lt.20344] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 4.4] [Reference Citation Analysis]
88 Kerkar N, Vergani D. De novo autoimmune hepatitis –is this different in adults compared to children? Journal of Autoimmunity 2018;95:26-33. [DOI: 10.1016/j.jaut.2018.10.023] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
89 Cainelli F, Vento S. Infections and solid organ transplant rejection: a cause-and-effect relationship? The Lancet Infectious Diseases 2002;2:539-49. [DOI: 10.1016/s1473-3099(02)00370-5] [Cited by in Crossref: 121] [Cited by in F6Publishing: 40] [Article Influence: 6.1] [Reference Citation Analysis]
90 Nakazawa Y, Jonsson JR, Walker NI, Kerlin P, Steadman C, Lynch SV, Strong RW, Clouston AD. Fibrous obliterative lesions of veins contribute to progressive fibrosis in chronic liver allograft rejection: Fibrous obliterative lesions of veins contribute to progressive fibrosis in chronic liver allograft rejection. Hepatology 2000;32:1240-7. [DOI: 10.1053/jhep.2000.20350] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
91 Herzog D, Soglio DB, Fournet JC, Martin S, Marleau D, Alvarez F. Interface hepatitis is associated with a high incidence of late graft fibrosis in a group of tightly monitored pediatric orthotopic liver transplantation patients. Liver Transpl. 2008;14:946-955. [PMID: 18581476 DOI: 10.1002/lt.21444] [Cited by in Crossref: 52] [Cited by in F6Publishing: 40] [Article Influence: 3.7] [Reference Citation Analysis]
92 Dao M, Habès D, Taupin JL, Mussini C, Redon MJ, Suberbielle C, Jacquemin E, Gonzales E, Guettier C. Morphological characterization of chronic antibody-mediated rejection in ABO-identical or ABO-compatible pediatric liver graft recipients. Liver Transpl 2018;24:897-907. [PMID: 29704327 DOI: 10.1002/lt.25187] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
93 van der Leij J, van den Berg A, Albrecht EWJA, Blokzijl T, Roozendaal R, Gouw ASH, de Jong KP, Stegeman CA, van Goor H, Chang N, Poppema S. High expression of TIAF-1 in chronic kidney and liver allograft rejection and in activated T-helper cells1: . Transplantation 2003;75:2076-82. [DOI: 10.1097/01.tp.0000069829.71088.88] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
94 Goddard S, Adams DH. New approaches to immunosuppression in liver transplantation. Journal of Gastroenterology and Hepatology 2002;17:116-26. [DOI: 10.1046/j.1440-1746.2002.02633.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
95 Kim YK, Kim SH, Moon IS, Han SS, Cho SY, You T, Park SJ. The effect of a positive T-lymphocytotoxic crossmatch on clinical outcomes in adult-to-adult living donor liver transplantation. J Korean Surg Soc 2013;84:245-51. [PMID: 23577320 DOI: 10.4174/jkss.2013.84.4.245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
96 Satapathy SK, Sclair S, Fiel MI, Del Rio Martin J, Schiano T. Clinical characterization of patients developing histologically-proven fibrosing cholestatic hepatitis C post-liver transplantation. Hepatol Res. 2011;41:328-339. [PMID: 21426450 DOI: 10.1111/j.1872-034x.2011.00781.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 10] [Article Influence: 4.4] [Reference Citation Analysis]
97 Chen L, Shi X, Lv G, Sun X, Sun C, Cai Y, Niu J, Jin J, Liu N, Li W. The long-term outcomes of deceased-donor liver transplantation for primary biliary cirrhosis: a two-center study in China. PeerJ 2020;8:e9563. [PMID: 32879788 DOI: 10.7717/peerj.9563] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
98 Demetris AJ, Lunz JG 3rd, Randhawa P, Wu T, Nalesnik M, Thomson AW. Monitoring of human liver and kidney allograft tolerance: a tissue/histopathology perspective. Transpl Int 2009;22:120-41. [PMID: 18980624 DOI: 10.1111/j.1432-2277.2008.00765.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 3.4] [Reference Citation Analysis]
99 Eggers V, Pascher A, Althoff H, Thiele S, Mutze J, Selignow J, Neuhaus P, Spies CD. Immune Reactivity Is More Suppressed in Patients with Alcoholic Liver Disease than in Patients with Virus-Induced Cirrhosis after CRH Stimulation. Alcoholism Clin Exp Res 2006;30:140-9. [DOI: 10.1111/j.1530-0277.2006.00014.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
100 Miyagawa-Hayashino A, Tsuruyama T, Egawa H, Haga H, Sakashita H, Okuno T, Toyokuni S, Tamaki K, Yamabe H, Manabe T. FasL expression in hepatic antigen-presenting cells and phagocytosis of apoptotic T cells by FasL+ Kupffer cells are indicators of rejection activity in human liver allografts. Am J Pathol. 2007;171:1499-1508. [PMID: 17823283 DOI: 10.2353/ajpath.2007.070027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
101 Walter T, Dumortier J, Guillaud O, Hervieu V, Paliard P, Scoazec JY, Boillot O. Rejection under alpha interferon therapy in liver transplant recipients. Am J Transplant. 2007;7:177-184. [PMID: 17227566 DOI: 10.1111/j.1600-6143.2006.01590.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
102 Dufour DR. Liver Disease. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Elsevier; 2012. pp. 1637-93. [DOI: 10.1016/b978-1-4160-6164-9.00050-0] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
103 Rodriguez E. The pathology of heart transplant biopsy specimens: revisiting the 1990 ISHLT working formulation. The Journal of Heart and Lung Transplantation 2003;22:3-15. [DOI: 10.1016/s1053-2498(02)00575-2] [Cited by in Crossref: 41] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
104 Fiel MI, Agarwal K, Stanca C, Elhajj N, Kontorinis N, Thung SN, Schiano TD. Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus. Liver Transpl 2008;14:861-71. [DOI: 10.1002/lt.21447] [Cited by in Crossref: 93] [Cited by in F6Publishing: 68] [Article Influence: 6.6] [Reference Citation Analysis]
105 Souza P, Prihoda TJ, Hoyumpa AM, Sharkey FE. Morphologic features resembling transplant rejection in core biopsies of native livers from patients with Hepatitis C. Human Pathology 2009;40:92-7. [DOI: 10.1016/j.humpath.2008.06.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
106 Wiesner RH, Rakela J, Ishitani MB, Mulligan DC, Spivey JR, Steers JL, Krom RA. Recent advances in liver transplantation. Mayo Clin Proc. 2003;78:197-210. [PMID: 12583530 DOI: 10.4065/78.2.197] [Cited by in Crossref: 69] [Cited by in F6Publishing: 48] [Article Influence: 3.6] [Reference Citation Analysis]
107 Nenadic IZ, Qiang B, Urban MW, Zhao H, Sanchez W, Greenleaf JF, Chen S. Attenuation measuring ultrasound shearwave elastography and in vivo application in post-transplant liver patients. Phys Med Biol 2017;62:484-500. [PMID: 28000623 DOI: 10.1088/1361-6560/aa4f6f] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
108 Moreira RK. Recurrent hepatitis C and acute allograft rejection: clinicopathologic features with emphasis on the differential diagnosis between these entities. Adv Anat Pathol. 2011;18:393-405. [PMID: 21841407 DOI: 10.1097/pap.0b013e31822a5a10] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
109 Ekong UD, Gupta NA, Urban R, Andrews WS. 20‐ to 25‐year patient and graft survival following a single pediatric liver transplant—Analysis of the United Network of Organ Sharing database: Where to go from here. Pediatr Transplant 2019;23. [DOI: 10.1111/petr.13523] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
110 Choudhary NS, Saraf N, Saigal S, Gautam D, Rastogi A, Goja S, Bhangui P, Srinivasan T, Yadav SK, Soin A. Revisiting chronic rejection following living donor liver transplantation in the tacrolimus era: A single center experience. Clin Transplant 2018;32:e13161. [DOI: 10.1111/ctr.13161] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
111 Quintero Bernabeu J, Juamperez J, Muñoz M, Rodriguez O, Vilalta R, Molino JA, Asensio M, Bilbao I, Ariceta G, Rodrigo C, Charco R. Successful long-term outcome of pediatric liver-kidney transplantation: a single-center study. Pediatr Nephrol 2018;33:351-8. [PMID: 28842757 DOI: 10.1007/s00467-017-3782-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
112 Duclos-Vallee JC, Sebagh M. Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation. Liver Transpl. 2009;15 Suppl 2:S25-S34. [PMID: 19876939 DOI: 10.1002/lt.21916] [Cited by in Crossref: 73] [Cited by in F6Publishing: 53] [Article Influence: 6.1] [Reference Citation Analysis]
113 O'Leary JG, Kaneku H, Susskind BM, Jennings LW, Neri MA, Davis GL, Klintmalm GB, Terasaki PI. High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant. Am J Transplant 2011;11:1868-76. [PMID: 21672151 DOI: 10.1111/j.1600-6143.2011.03593.x] [Cited by in Crossref: 125] [Cited by in F6Publishing: 105] [Article Influence: 11.4] [Reference Citation Analysis]
114 Longerich T, Flechtenmacher C, Schirmacher P. [Quality and quantity in hepatopathology. Diagnostic and clinically relevant grading for non-tumourous liver diseases]. Pathologe 2008;29:15-26. [PMID: 18210114 DOI: 10.1007/s00292-007-0963-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
115 Ekong UD, McKiernan P, Martinez M, Lobritto S, Kelly D, Ng VL, Alonso EM, Avitzur Y. Long-term outcomes of de novo autoimmune hepatitis in pediatric liver transplant recipients. Pediatr Transplant. 2017;21. [PMID: 28556542 DOI: 10.1111/petr.12945] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
116 Ueda Y, Kaido T, Ito T, Ogawa K, Yoshizawa A, Fujimoto Y, Mori A, Miyagawa-Hayashino A, Haga H, Marusawa H, Chiba T, Uemoto S. Chronic rejection associated with antiviral therapy for recurrent hepatitis C after living-donor liver transplantation. Transplantation 2014;97:344-50. [PMID: 24157473 DOI: 10.1097/01.TP.0000435702.61642.0a] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
117 Mells G, Neuberger J. Protocol liver allograft biopsies. Transplantation. 2008;85:1686-1692. [PMID: 18580457 DOI: 10.1097/tp.0b013e318176b1fd] [Cited by in Crossref: 34] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
118 Sugawara Y, Makuuchi M, Kaneko J, Saiura A, Imamura H, Kokudo N. Risk factors for acute rejection in living donor liver transplantation: HLA matching in LDLT. Clinical Transplantation 2003;17:347-52. [DOI: 10.1034/j.1399-0012.2003.00057.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
119 Curry MP. Systematic investigation of elevated transaminases during the third posttransplant month. Liver Transpl. 2013;19 Suppl 2:S17-S22. [PMID: 24019297 DOI: 10.1002/lt.23737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
120 Mandal S, Miraglia R, Maruzzelli L, Liotta R, Tuzzolino F, Spada M, Riva S, Luca A. US-guided percutaneous liver biopsy in pediatric liver transplant recipients. J Pediatr Gastroenterol Nutr 2014;58:756-61. [PMID: 24509302 DOI: 10.1097/MPG.0000000000000328] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
121 Wiesner RH, Menon KV. Late hepatic allograft dysfunction. Liver Transpl. 2001;7:S60-S73. [PMID: 11689778 DOI: 10.1053/jlts.2001.29094] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
122 Ueno T, Zenitani M, Yamanaka H, Tanaka N, Uehara S, Tazuke Y, Bessho K, Okuyama H. Impact of Donor-Specific Antibodies on Graft Fibrosis After Pediatric Living Donor Liver Transplantation for Biliary Atresia. Transplant Proc. 2016;48:1095-1099. [PMID: 27320565 DOI: 10.1016/j.transproceed.2016.02.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
123 Huang HJ, Zheng ZY, Yu YH. Advances in research on antibody-mediated rejection after liver transplantation. Shijie Huaren Xiaohua Zazhi 2009; 17(33): 3420-3425 [DOI: 10.11569/wcjd.v17.i33.3420] [Reference Citation Analysis]
124 Krukemeyer MG, Moeller J, Morawietz L, Rudolph B, Neumann U, Theruvath T, Neuhaus P, Krenn V. Description of B lymphocytes and plasma cells, complement, and chemokines/receptors in acute liver allograft rejection. Transplantation. 2004;78:65-70. [PMID: 15257040 DOI: 10.1097/01.TP.0000132324.14207.8B] [Cited by in Crossref: 68] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
125 Hillebrands JL, Klatter FA, van den Hurk BM, Popa ER, Nieuwenhuis P, Rozing J. Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis. J Clin Invest. 2001;107:1411-1422. [PMID: 11390423 DOI: 10.1172/jci10233] [Cited by in Crossref: 213] [Cited by in F6Publishing: 40] [Article Influence: 10.1] [Reference Citation Analysis]
126 Idilman R, Erden E, Kuzu I, Ersoz S, Karayalcin S. The fate of recipient-derived hepatocytes in sex-mismatched liver allograft following liver transplantation. Clin Transplant. 2007;21:202-206. [PMID: 17425745 DOI: 10.1111/j.1399-0012.2006.00623.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
127 Eksteen B, Neuberger JM. Mechanisms of Disease: the evolving understanding of liver allograft rejection. Nat Rev Gastroenterol Hepatol 2008;5:209-19. [DOI: 10.1038/ncpgasthep1070] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
128 Lucey MR. Serial liver biopsies: a gateway into understanding the long-term health of the liver allograft. J Hepatol. 2001;34:762-763. [PMID: 11434625 DOI: 10.1016/s0168-8278(01)00070-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
129 Samonakis DN, Mela M, Quaglia A, Triantos CK, Thalheimer U, Leandro G, Pesci A, Raimondo ML, Dhillon AP, Rolles K. Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis. Transpl Infect Dis. 2006;8:3-12. [PMID: 16623815 DOI: 10.1111/j.1399-3062.2006.00124.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
130 González-Koch A, Czaja AJ, Carpenter HA, Roberts SK, Charlton MR, Porayko MK, Rosen CB, Wiesner RH. Recurrent autoimmune hepatitis after orthotopic liver transplantation. Liver Transpl. 2001;7:302-310. [PMID: 11303289 DOI: 10.1053/jlts.2001.21449] [Cited by in Crossref: 142] [Cited by in F6Publishing: 109] [Article Influence: 6.8] [Reference Citation Analysis]
131 Lerut J, Mathys J, Verbaandert C, Talpe S, Ciccarelli O, Lemaire J, Bonaccorsi-Riani E, Vanthuyne V, Hetsch N, Roggen F, Reyck CD, Goffette P, Latinne D, Orlando G, Rahier J, Sempoux C, Wallemacq P, Laterre PF, Gianello P. Tacrolimus monotherapy in liver transplantation: one-year results of a prospective, randomized, double-blind, placebo-controlled study. Ann Surg 2008;248:956-67. [PMID: 19092340 DOI: 10.1097/SLA.0b013e31819009c9] [Cited by in Crossref: 45] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
132 Adams DH, Sanchez-Fueyo A, Samuel D. From immunosuppression to tolerance. J Hepatol. 2015;62:S170-S185. [PMID: 25920086 DOI: 10.1016/j.jhep.2015.02.042] [Cited by in Crossref: 83] [Cited by in F6Publishing: 72] [Article Influence: 13.8] [Reference Citation Analysis]
133 Kehar M, Parekh RS, Stunguris J, De Angelis M, Van Roestel K, Ghanekar A, Cattral M, Fecteau A, Ling S, Kamath BM, Jones N, Avitzur Y, Grant D, Ng VL. Superior Outcomes and Reduced Wait Times in Pediatric Recipients of Living Donor Liver Transplantation. Transplant Direct 2019;5:e430. [PMID: 30882035 DOI: 10.1097/TXD.0000000000000865] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
134 Oura T, Yamashita K, Suzuki T, Fukumori D, Watanabe M, Hirokata G, Wakayama K, Taniguchi M, Shimamura T, Miura T, Okimura K, Maeta K, Haga H, Kubota K, Shimizu A, Sakai F, Furukawa H, Todo S. Long-Term Hepatic Allograft Acceptance Based on CD40 Blockade by ASKP1240 in Nonhuman Primates: ASKP1240 Prevents Hepatic Rejection in NHPs. American Journal of Transplantation 2012;12:1740-54. [DOI: 10.1111/j.1600-6143.2012.04014.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
135 Ueda D, Hori T, Nguyen JH, Uemoto S. Muromonab-CD3 therapy for refractory rejections after liver transplantation: a single-center experience during two decades in Japan. Journal of Hepato-Biliary-Pancreatic Sciences 2010;17:885-91. [DOI: 10.1007/s00534-010-0288-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
136 Del Bello A, Danjoux M, Congy-jolivet N, Lavayssière L, Esposito L, Muscari F, Kamar N. Histological long-term outcomes from acute antibody-mediated rejection following ABO-compatible liver transplantation: Outcome of antibody mediated rejection. Journal of Gastroenterology and Hepatology 2017;32:887-93. [DOI: 10.1111/jgh.13613] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
137 Demetris A, Crawford JM, Minervini MI, Nalesnik M, Ochoa E, Randhawa P, Sasatomi E, Wu T. Transplantation Pathology of the Liver. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. Elsevier; 2009. pp. 1169-229. [DOI: 10.1016/b978-141604059-0.50047-3] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
138 Schotters FL, Beime J, Briem-Richter A, Binder T, Herden U, Grabhorn EF. Impact of donor-specific antibodies on long-term graft survival with pediatric liver transplantation. World J Hepatol 2021; 13(6): 673-685 [PMID: 34239702 DOI: 10.4254/wjh.v13.i6.673] [Reference Citation Analysis]
139 Hashimoto S, Onoe T, Banshodani M, Taguchi K, Tanaka Y, Ohdan H. Postoperative Portal Hypertension Enhances Alloimmune Responses after Living-Donor Liver Transplantation in Patients and in a Mouse Model. J Immunol 2019;203:1392-403. [PMID: 31331971 DOI: 10.4049/jimmunol.1701147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
140 Takahashi H, Kato T, Delacruz V, Nishida S, Selvaggi G, Weppler D, Island E, Moon JI, Levi DM, Tzakis AG, Ruiz P. Analysis of Acute and Chronic Rejection in Multiple Organ Allografts From Retransplantation and Autopsy Cases of Multivisceral Transplantation. Transplantation 2008;85:1610-6. [DOI: 10.1097/tp.0b013e318174d857] [Cited by in Crossref: 18] [Article Influence: 1.3] [Reference Citation Analysis]
141 Oh SH, Kim KM, Kim DY, Lee YJ, Rhee KW, Jang JY, Chang SH, Lee SY, Kim JS, Choi BH. Long-term outcomes of pediatric living donor liver transplantation at a single institution. Pediatr Transplant. 2010;14:870-878. [PMID: 20609169 DOI: 10.1111/j.1399-3046.2010.01357.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
142 Ekong UD, Melin-Aldana H, Seshadri R, Lokar J, Harris D, Whitington PF, Alonso EM. Graft histology characteristics in long-term survivors of pediatric liver transplantation. Liver Transpl. 2008;14:1582-1587. [PMID: 18975292 DOI: 10.1002/lt.21549] [Cited by in Crossref: 102] [Cited by in F6Publishing: 76] [Article Influence: 7.8] [Reference Citation Analysis]
143 Demetris AJ, III JGL, Specht S, Nozaki I. Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease. World J Gastroenterol 2006; 12(22): 3512-3522 [PMID: 16773708 DOI: 10.3748/wjg.v12.i22.3512] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 36] [Article Influence: 2.1] [Reference Citation Analysis]
144 Angelico R, Gerlach UA, Gunson BK, Neil D, Mergental H, Isaac J, Muiesan P, Mirza D, Perera MTP. Severe Unresolved Cholestasis Due to Unknown Etiology Leading to Early Allograft Failure Within the First 3 Months of Liver Transplantation. Transplantation 2018;102:1307-15. [DOI: 10.1097/tp.0000000000002139] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
145 Gouw AS, van den Heuvel MC, van den Berg AP, Slooff MJ, de Jong KP, Poppema S. The significance of parenchymal changes of acute cellular rejection in predicting chronic liver graft rejection. Transplantation. 2002;73:243-247. [PMID: 11821738 DOI: 10.1097/00007890-200201270-00016] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
146 Lefkowitch JH. Pathology of the liver. Curr Opin Gastroenterol 2001;17:197-204. [PMID: 17031160 DOI: 10.1097/00001574-200105000-00002] [Reference Citation Analysis]
147 Fiel MI, Schiano T. Acute cellular rejection and its sequelae developing in a 42-year-old man after liver transplantation. Hepatology 2009;50:650-1. [PMID: 19642164 DOI: 10.1002/hep.23161] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
148 Debray D, Furlan V, Baudouin V, Houyel L, Lacaille F, Chardot C. Therapy for acute rejection in pediatric organ transplant recipients. Paediatr Drugs 2003;5:81-93. [PMID: 12529161 DOI: 10.2165/00128072-200305020-00002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
149 Vandevoorde K, Ducreux S, Bosch A, Guillaud O, Hervieu V, Chambon-Augoyard C, Poinsot D, André P, Scoazec JY, Robinson P, Boillot O, Dubois V, Dumortier J. Prevalence, Risk Factors, and Impact of Donor-Specific Alloantibodies After Adult Liver Transplantation. Liver Transpl 2018;24:1091-100. [PMID: 29665189 DOI: 10.1002/lt.25177] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
150 Koukoulis GK, Shen J, Karademir S, Jensen D, Williams J. Cholangiocytic apoptosis in chronic ductopenic rejection. Hum Pathol 2001;32:823-7. [PMID: 11521226 DOI: 10.1053/hupa.2001.26465] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
151 Angelico R, Spada M, Liccardo D, Pedini D, Grimaldi C, Pietrobattista A, Basso MS, Della Corte C, Mosca A, Saffioti MC, Alaggio R, Maggiore G, Candusso M, Francalanci P. Allograft Fibrosis After Pediatric Liver Transplantation: Incidence, Risk Factors, and Evolution. Liver Transpl 2021. [PMID: 34164907 DOI: 10.1002/lt.26218] [Reference Citation Analysis]
152 Nagai S, Ito M, Kamei H, Nakamura T, Ando H, Kiuchi T. Indirect immunohistochemical evaluation of graft fibrosis and interface hepatitis after pediatric liver transplantation. Pediatr Transplant. 2010;14:342-350. [PMID: 19744282 DOI: 10.1111/j.1399-3046.2009.01234.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
153 Shaked A, DesMarais MR, Kopetskie H, Feng S, Punch JD, Levitsky J, Reyes J, Klintmalm GB, Demetris AJ, Burrell BE, Priore A, Bridges ND, Sayre PH. Outcomes of immunosuppression minimization and withdrawal early after liver transplantation. Am J Transplant 2019;19:1397-409. [PMID: 30506630 DOI: 10.1111/ajt.15205] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
154 Ghinolfi D, Marti J, De Simone P, Lai Q, Pezzati D, Coletti L, Tartaglia D, Catalano G, Tincani G, Carrai P, Campani D, Miccoli M, Biancofiore G, Filipponi F. Use of octogenarian donors for liver transplantation: a survival analysis. Am J Transplant. 2014;14:2062-2071. [PMID: 25307037 DOI: 10.1111/ajt.12843] [Cited by in Crossref: 72] [Cited by in F6Publishing: 57] [Article Influence: 9.0] [Reference Citation Analysis]
155 Kaneku H, O'Leary JG, Taniguchi M, Susskind BM, Terasaki PI, Klintmalm GB. Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with chronic rejection and graft loss after liver transplantation. Liver Transpl 2012;18:984-92. [PMID: 22508525 DOI: 10.1002/lt.23451] [Cited by in Crossref: 108] [Cited by in F6Publishing: 94] [Article Influence: 10.8] [Reference Citation Analysis]
156 Lee J, Romero R, Xu Y, Kim JS, Park JY, Kusanovic JP, Chaiworapongsa T, Hassan SS, Kim CJ. Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis: evidence in support of the chronic nature of maternal anti-fetal rejection. Am J Reprod Immunol 2011;66:510-26. [PMID: 21951517 DOI: 10.1111/j.1600-0897.2011.01066.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
157 Abraham SC, Freese DK, Ishitani MB, Krasinskas AM, Wu TT. Significance of central perivenulitis in pediatric liver transplantation. Am J Surg Pathol. 2008;32:1479-1488. [PMID: 18708942 DOI: 10.1097/pas.0b013e31817a8e96] [Cited by in Crossref: 38] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
158 Egawa H, Teramukai S, Haga H, Tanabe M, Mori A, Ikegami T, Kawagishi N, Ohdan H, Kasahara M, Umeshita K. Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study. Am J Transplant. 2014;14:102-114. [PMID: 24279828 DOI: 10.1111/ajt.12520] [Cited by in Crossref: 91] [Cited by in F6Publishing: 79] [Article Influence: 10.1] [Reference Citation Analysis]
159 Bonhomme-Faivre L, Devocelle A, Saliba F, Chatled S, Maccario J, Farinotti R, Picard V. MDR-1 C3435T polymorphism influences cyclosporine a dose requirement in liver-transplant recipients. Transplantation 2004;78:21-5. [PMID: 15257034 DOI: 10.1097/01.tp.0000130981.55654.78] [Cited by in Crossref: 63] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
160 Westerholt A, Himpel S, Hager-gensch B, Maier S, Werner M, Stadler J, Doehmer J, Heidecke C. Intragraft iNOS induction during human liver allograft rejection depresses cytochrome p450 activity. Transplant Int 2004;17:370-8. [DOI: 10.1111/j.1432-2277.2004.tb00457.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
161 Sebagh M, Blakolmer K, Falissard B, Roche B, Emile J, Bismuth H, Samuel D, Reynès M. Accuracy of bile duct changes for the diagnosis of chronic liver allograft rejection: Reliability of the 1999 Banff schema: Accuracy of bile duct changes for the diagnosis of chronic liver allograft rejection: Reliability of the 1999 Banff schema. Hepatology 2002;35:117-25. [DOI: 10.1053/jhep.2002.30085] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
162 Venturi C, Sempoux C, Bueno J, Ferreres Pinas JC, Bourdeaux C, Abarca-Quinones J, Rahier J, Reding R. Novel histologic scoring system for long-term allograft fibrosis after liver transplantation in children. Am J Transplant. 2012;12:2986-2996. [PMID: 22882699 DOI: 10.1111/j.1600-6143.2012.04210.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 6.6] [Reference Citation Analysis]
163 Hassoun Z, Shah V, Petrovic LM. The choice of calcineurin inhibitor does not influence centrilobular necrosis after orthotopic liver transplantation. Transplant Proc 2002;34:1519-20. [PMID: 12176464 DOI: 10.1016/s0041-1345(02)02955-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
164 Hassoun Z, Shah V, Lohse CM, Pankratz VS, Petrovic LM. Centrilobular necrosis after orthotopic liver transplantation: Association with acute cellular rejection and impact on outcome. Liver Transpl 2004;10:480-7. [DOI: 10.1002/lt.20122] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
165 Czaja AJ. Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance. Liver Transpl. 2002;8:505-513. [PMID: 12037780 DOI: 10.1053/jlts.2002.33485] [Cited by in Crossref: 78] [Cited by in F6Publishing: 66] [Article Influence: 3.9] [Reference Citation Analysis]
166 Kimura Y, Taura K, Hai Nam N, Uemoto Y, Yoshino K, Ikeno Y, Okuda Y, Nishio T, Yamamoto G, Tanabe K, Koyama Y, Anazawa T, Fukumitsu K, Ito T, Yagi S, Kamo N, Seo S, Iwaisako K, Hata K, Imai T, Uemoto S. Utility of Mac-2 Binding Protein Glycosylation Isomer to Evaluate Graft Status After Liver Transplantation. Liver Transpl 2021;27:403-15. [PMID: 32780942 DOI: 10.1002/lt.25870] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
167 Dumortier J, Guillaud O, Boillot O. Conversion from twice daily tacrolimus to once daily tacrolimus in long-term stable liver transplant recipients: A single-center experience with 394 patients: Conversion from Twice Daily to Once Daily Tacrolimus. Liver Transpl 2013;19:529-33. [DOI: 10.1002/lt.23638] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
168 Walter T, Scoazec JY, Guillaud O, Hervieu V, Chevallier P, Boillot O, Dumortier J. Long-term antiviral therapy for recurrent hepatitis C after liver transplantation in nonresponders: biochemical, virological, and histological impact. Liver Transpl. 2009;15:54-63. [PMID: 19109834 DOI: 10.1002/lt.21652] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
169 Yu YY, Ji J, Zhou GW, Shen BY, Chen H, Yan JQ, Peng CH, Li HW. Liver biopsy in evaluation of complications following liver transplantation. World J Gastroenterol 2004; 10(11): 1678-1681 [PMID: 15162551 DOI: 10.3748/wjg.v10.i11.1678] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
170 Baron D, Giral M, Brouard S. Reconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomes. Transpl Int 2015;28:938-59. [DOI: 10.1111/tri.12578] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
171 Jain A, Mazariegos G, Kashyap R, Kosmach-Park B, Starzl TE, Fung J, Reyes J. Pediatric liver transplantation. A single center experience spanning 20 years. Transplantation. 2002;73:941-947. [PMID: 11923697 DOI: 10.1097/00007890-200203270-00020] [Cited by in Crossref: 107] [Cited by in F6Publishing: 82] [Article Influence: 5.4] [Reference Citation Analysis]
172 Beyzaei Z, Geramizadeh B, Bagheri Z, Karimzadeh S, Shojazadeh A. De Novo Donor Specific Antibody and Long-Term Outcome After Liver Transplantation: A Systematic Review and Meta-Analysis. Front Immunol 2020;11:613128. [PMID: 33424868 DOI: 10.3389/fimmu.2020.613128] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
173 Cuervo Florez M, Bruner J, Zarrinpar A. Progress and challenges in diagnosis and treatment of rejection following liver transplantation. Curr Opin Organ Transplant 2021;26:669-74. [PMID: 34581291 DOI: 10.1097/MOT.0000000000000924] [Reference Citation Analysis]
174 Ward C, Robertson H, Forrest IA, Lordan J, Murphy D, Dark JH, Corris PA, Jones DE, Kirby JA. Hypothesis: epithelial-to-mesenchymal transition is a common cause of chronic allograft failure. Transplant Proc. 2005;37:977-980. [PMID: 15848596 DOI: 10.1016/j.transproceed.2004.12.203] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
175 Carbone M, Neuberger JM. Autoimmune liver disease, autoimmunity and liver transplantation. J Hepatol. 2014;60:210-223. [PMID: 24084655 DOI: 10.1016/j.jhep.2013.09.020] [Cited by in Crossref: 119] [Cited by in F6Publishing: 93] [Article Influence: 13.2] [Reference Citation Analysis]
176 Mitchell O, Cosar AM, Malik MU, Gurakar A. Late liver function test abnormalities post-adult liver transplantation: a review of the etiology, investigation, and management. Hepatol Int 2016;10:106-14. [PMID: 26603541 DOI: 10.1007/s12072-015-9685-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
177 Sousa JM, Barrera L, Gomez-Bravo MA, Nuñez-Roldan A, Aguilera I. Glutathione S-Transferase T1 Mismatch Is a Risk Factor for Chronic Ductopenic Rejection of Liver Allografts. Liver Transpl 2020;26:1287-97. [PMID: 32510757 DOI: 10.1002/lt.25815] [Reference Citation Analysis]
178 Usui M, Kuriyama N, Kisawada M, Hamada T, Mizuno S, Sakurai H, Tabata M, Imai H, Okamoto K, Uemoto S. Tissue factor expression demonstrates severe sinusoidal endothelial cell damage during rejection after living-donor liver transplantation. J Hepatobiliary Pancreat Surg. 2009;16:513-520. [PMID: 19370302 DOI: 10.1007/s00534-009-0095-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
179 MacQuillan GC, de Boer WB, Allan JE, Platten MA, Reed WD, Jeffrey GP. Hepatocellular MxA protein expression supports the differentiation of recurrent hepatitis C disease from acute cellular rejection after liver transplantation. Clin Transplant. 2010;24:252-258. [PMID: 19712085 DOI: 10.1111/j.1399-0012.2009.01068.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
180 Duclos-vallee J, Yilmaz F, Johanet C, Roque-afonso A, Gigou M, Trichet C, Feray C, Ballot E, Dussaix E, Castaing D, Bismuth H, Samuel D, Guettier C. Could post-liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis? Clin Transplant 2005;19:591-9. [DOI: 10.1111/j.1399-0012.2004.00323.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
181 Skogsberg Dahlgren U, Herlenius G, Gustafsson B, Mölne J, Rydberg L, Socratous A, Bennet W. Excellent outcome following emergency deceased donor ABO-incompatible liver transplantation using rituximab and antigen specific immunoadsorption. Scand J Gastroenterol 2021;:1-10. [PMID: 34541993 DOI: 10.1080/00365521.2021.1976269] [Reference Citation Analysis]
182 Kasahara M, Kiuchi T, Uryuhara K, Uemoto S, Fujimoto Y, Ogura Y, Oike F, Kaihara S, Egawa H, Tanaka K. Role of HLA compatibility in pediatric living-related liver transplantation1: . Transplantation 2002;74:1175-80. [DOI: 10.1097/00007890-200210270-00020] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
183 Sanei MH, Schiano TD, Sempoux C, Fan C, Fiel MI. Acute Cellular Rejection Resulting in Sinusoidal Obstruction Syndrome and Ascites Postliver Transplantation. Transplantation 2011;92:1152-8. [DOI: 10.1097/tp.0b013e318234119d] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
184 Evans PC, Smith S, Hirschfield G, Rigopoulou E, Wreghitt TG, Wight DG, Taylor CJ, Alexander GJ. Recipient HLA-DR3, tumour necrosis factor-alpha promoter allele-2 (tumour necrosis factor-2) and cytomegalovirus infection are interrelated risk factors for chronic rejection of liver grafts. J Hepatol. 2001;34:711-715. [PMID: 11434617 DOI: 10.1016/s0168-8278(00)00101-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
185 Booth IA, Clark JE, LaMattina JC, Barth RN, Haririan A, Ravichandran BR. The Impact of Treatment Delay on Hepatitis C Liver Transplant Outcomes. J Pharm Pract 2021;:8971900211034261. [PMID: 34289722 DOI: 10.1177/08971900211034261] [Reference Citation Analysis]
186 Taner T, Stegall MD, Heimbach JK. Antibody-mediated rejection in liver transplantation: current controversies and future directions. Liver Transpl 2014;20:514-27. [PMID: 24470340 DOI: 10.1002/lt.23826] [Cited by in Crossref: 44] [Cited by in F6Publishing: 31] [Article Influence: 5.5] [Reference Citation Analysis]
187 Manzia TM, Angelico R, Baiocchi L, Toti L, Ciano P, Palmieri G, Angelico M, Orlando G, Tisone G. The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up. Transpl Int 2013;26:259-66. [DOI: 10.1111/tri.12023] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
188 Hübscher SG. Transplantation pathology. Seminars in Diagnostic Pathology 2006;23:170-81. [DOI: 10.1053/j.semdp.2006.11.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
189 Longerich T, Schirmacher P. General aspects and pitfalls in liver transplant pathology. Clin Transplant 2006;20 Suppl 17:60-8. [PMID: 17100703 DOI: 10.1111/j.1399-0012.2006.00602.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
190 Langer G, Saal S, Großmann K, Grothues D, Wienke A, Langer G. Glucocorticosteroids for liver transplanted patients. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd007606] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
191 Miyagawa-Hayashino A, Egawa H, Yorifuji T, Hasegawa M, Haga H, Tsuruyama T, Wen MC, Sumazaki R, Manabe T, Uemoto S. Allograft steatohepatitis in progressive familial intrahepatic cholestasis type 1 after living donor liver transplantation. Liver Transpl. 2009;15:610-618. [PMID: 19479804 DOI: 10.1002/lt.21686] [Cited by in Crossref: 62] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
192 Ghabril M, Dickson RC, Machicao VI, Aranda-Michel J, Keaveny A, Rosser B, Bonatti H, Krishna M, Yataco M, Satyanarayana R, Harnois D, Hewitt W, Willingham DD, Grewal H, Hughes CB, Nguyen J. Liver retransplantation of patients with hepatitis C infection is associated with acceptable patient and graft survival. Liver Transpl 2007;13:1717-27. [PMID: 18044750 DOI: 10.1002/lt.21292] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
193 Azarpira N, Aghdaie MH, Kazemi K, Geramizadeh B, Darai M. HLA-G polymorphism (rs16375) and acute rejection in liver transplant recipients. Dis Markers 2014;2014:814182. [PMID: 24591768 DOI: 10.1155/2014/814182] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
194 Kasahara M, Takada Y, Egawa H, Fujimoto Y, Ogura Y, Ogawa K, Kozaki K, Haga H, Ueda M, Tanaka K. Auxiliary partial orthotopic living donor liver transplantation: Kyoto University experience. Am J Transplant. 2005;5:558-565. [PMID: 15707411 DOI: 10.1111/j.1600-6143.2005.00717.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 58] [Article Influence: 4.4] [Reference Citation Analysis]
195 Della-Guardia B, Almeida MD, Meira-Filho SP, Torres MA, Venco F, Afonso RC, Ferraz-Neto BH. Antibody-mediated rejection: hyperacute rejection reality in liver transplantation? A case report. Transplant Proc. 2008;40:870-871. [PMID: 18455039 DOI: 10.1016/j.transproceed.2008.02.061] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
196 Shimizu A, Ishii E, Kuwahara N, Arai T, Kanzaki G, Higo S, Kajimoto Y, Nagasaka S, Masuda Y, Fukuda Y. Chronic Antibody-Mediated Responses May Mediate Chronic Rejection in Rat Orthotopic Liver Transplantation. Transplantation Proceedings 2013;45:1743-7. [DOI: 10.1016/j.transproceed.2013.02.045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
197 Wei W, Huang XH, Liang D, Zeng YY, Ma C, Wu YB, Li YT, Zhang X, Zeng JH, Liu JF. A proteomic analysis of transplanted liver in a rat model of chronic rejection. Clin Res Hepatol Gastroenterol 2015;39:340-50. [PMID: 25468549 DOI: 10.1016/j.clinre.2014.10.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
198 Selzner N, Renner EL, Selzner M, Adeyi O, Kashfi A, Therapondos G, Girgrah N, Herath C, Levy GA, Lilly L. Antiviral treatment of recurrent hepatitis C after liver transplantation: predictors of response and long-term outcome. Transplantation. 2009;88:1214-1221. [PMID: 19935376 DOI: 10.1097/tp.0b013e3181bd783c] [Cited by in Crossref: 103] [Cited by in F6Publishing: 20] [Article Influence: 8.6] [Reference Citation Analysis]
199 Levitsky J, Fiel MI, Norvell JP, Wang E, Watt KD, Curry MP, Tewani S, McCashland TM, Hoteit MA, Shaked A, Saab S, Chi AC, Tien A, Schiano TD. Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon. Gastroenterology. 2012;142:1132-1139.e1. [PMID: 22285805 DOI: 10.1053/j.gastro.2012.01.030] [Cited by in Crossref: 82] [Cited by in F6Publishing: 62] [Article Influence: 8.2] [Reference Citation Analysis]
200 Kok B, Dong V, Karvellas CJ. Graft Dysfunction and Management in Liver Transplantation. Crit Care Clin 2019;35:117-33. [PMID: 30447775 DOI: 10.1016/j.ccc.2018.08.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
201 Demetris AJ, Ruppert K, Dvorchik I, Jain A, Minervini M, Nalesnik MA, Randhawa P, Wu T, Zeevi A, Abu-elmagd K, Eghtesad B, Fontes P, Cacciarelli T, Marsh W, Geller D, Fung JJ. Real-time monitoring of acute liver-allograft rejection using the Banff schema1: . Transplantation 2002;74:1290-6. [DOI: 10.1097/00007890-200211150-00016] [Cited by in Crossref: 74] [Cited by in F6Publishing: 52] [Article Influence: 3.7] [Reference Citation Analysis]
202 Burton JR, Rosen HR. Diagnosis and Management of Allograft Failure. Clinics in Liver Disease 2006;10:407-35. [DOI: 10.1016/j.cld.2006.05.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
203 Del Bello A, Congy-Jolivet N, Danjoux M, Muscari F, Lavayssière L, Esposito L, Hebral AL, Bellière J, Kamar N. High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation. World J Gastroenterol 2018; 24(16): 1795-1802 [PMID: 29713132 DOI: 10.3748/wjg.v24.i16.1795] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]
204 Angaswamy N, Tiriveedhi V, Sarma NJ, Subramanian V, Klein C, Wellen J, Shenoy S, Chapman WC, Mohanakumar T. Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection. Hum Immunol 2013;74:1478-85. [PMID: 23876679 DOI: 10.1016/j.humimm.2013.07.002] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 6.4] [Reference Citation Analysis]
205 Jara P, Hierro L. [Pediatric liver transplantation]. Gastroenterol Hepatol 2005;28:493-508. [PMID: 16185585 DOI: 10.1157/13079008] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
206 Haga H, Miyagawa-Hayashino A, Taira K, Morioka D, Egawa H, Takada Y, Manabe T, Uemoto S. Histological recurrence of autoimmune liver diseases after living-donor liver transplantation. Hepatol Res. 2007;37 Suppl 3:S463-S469. [PMID: 17931204 DOI: 10.1111/j.1872-034x.2007.00245.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
207 Gao LH, Zheng SS. Cytomegalovirus and chronic allograft rejection in liver transplantation. World J Gastroenterol 2004; 10(13): 1857-1861 [PMID: 15222023 DOI: 10.3748/wjg.v10.i13.1857] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
208 Crawford JM, Liu C. Liver and Biliary Tract. Robbins and Cotran Pathologic Basis of Disease. Elsevier; 2010. pp. 833-90. [DOI: 10.1016/b978-1-4377-0792-2.50023-7] [Cited by in Crossref: 10] [Article Influence: 0.8] [Reference Citation Analysis]
209 Tashiro H, Fudaba Y, Itoh H, Mizunuma K, Ohdan H, Itamoto T, Asahara T. Hepatocyte growth factor prevents chronic allograft dysfunction in liver-transplanted rats. Transplantation. 2003;76:761-765. [PMID: 14501849 DOI: 10.1097/01.tp.0000083040.50727.ce] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
210 Londoño Hurtado MC. [Histological lesions in the graft in patients with long-term survival after transplantation. Are protocol biopsies necessary?]. Gastroenterol Hepatol 2013;36:97-103. [PMID: 22770578 DOI: 10.1016/j.gastrohep.2012.03.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
211 Heidenhain C, Heise M, Jonas S, Ben-Asseur M, Puhl G, Mittler J, Thelen A, Schmidt S, Langrehr J, Neuhaus P. Retrograde reperfusion via vena cava lowers the risk of initial nonfunction but increases the risk of ischemic-type biliary lesions in liver transplantation--a randomized clinical trial. Transpl Int. 2006;19:738-748. [PMID: 16918535 DOI: 10.1111/j.1432-2277.2006.00347.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
212 Liu TC, Nguyen TT, Torbenson MS. Concurrent increase in mitosis and apoptosis: a histological pattern of hepatic arterial flow abnormalities in post-transplant liver biopsies. Mod Pathol 2012;25:1594-8. [PMID: 22766789 DOI: 10.1038/modpathol.2012.116] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
213 Jimenez-zepeda VH, Heilman RL, Engel RA, Carey EJ, Freeman C, Rakela J, Mulligan DC, Fonseca R, Stewart AK. Monoclonal Gammopathy of Undetermined Significance Does Not Affect Outcomes in Patients Undergoing Solid Organ Transplants. Transplantation 2011;92:570-4. [DOI: 10.1097/tp.0b013e318225db2c] [Cited by in Crossref: 25] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
214 Lin C, Sundaram SS, Hart J, Whitington PF. Subacute Nonsuppurative Cholangitis (Cholangitis Lenta) in Pediatric Liver Transplant Patients. Journal of Pediatric Gastroenterology & Nutrition 2007;45:228-33. [DOI: 10.1097/mpg.0b013e318074c5d0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
215 Miyagawa-Hayashino A, Tsuruyama T, Haga H, Oike F, Il-Deok K, Egawa H, Hiai H, Tanaka K, Manabe T. Arteriopathy in chronic allograft rejection in liver transplantation. Liver Transpl. 2004;10:513-519. [PMID: 15048794 DOI: 10.1002/lt.20081] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
216 Neves Souza L, de Martino RB, Sanchez-fueyo A, Rela M, Dhawan A, O'grady J, Heaton N, Quaglia A. Histopathology of 460 liver allografts removed at retransplantation: A shift in disease patterns over 27 years. Clin Transplant 2018;32:e13227. [DOI: 10.1111/ctr.13227] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
217 Wan R, Ying W, Zeng L, Deng X, Chen H, Gao L. Antibody-Mediated Response in Rat Liver Chronic Rejection. Transplantation Proceedings 2011;43:1976-9. [DOI: 10.1016/j.transproceed.2011.03.043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
218 Naini BV, Lassman CR. Liver Transplant Pathology: Review of Challenging Diagnostic Situations. Surg Pathol Clin 2013;6:277-93. [PMID: 26838975 DOI: 10.1016/j.path.2013.03.004] [Reference Citation Analysis]
219 Schmitt TM, Phillips M, Sawyer RG, Northup P, Hagspiel KD, Pruett TL, Bonatti HJ. Anti-thymocyte globulin for the treatment of acute cellular rejection following liver transplantation. Dig Dis Sci. 2010;55:3224-3234. [PMID: 20238251 DOI: 10.1007/s10620-010-1149-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
220 Ali MA, Elshobari MM, Salah T, Kandeel AR, Sultan AM, Elghawalby AN, Shehta A, Elsayed U, Fathy O, Yassen A, Wahab MA. Impact of donor-recipient genetic relationship on outcome of living donor liver transplantation. Liver Transpl 2017;23:43-9. [PMID: 27516392 DOI: 10.1002/lt.24599] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
221 Neil DA, Hübscher SG. Current views on rejection pathology in liver transplantation. Transpl Int. 2010;23:971-983. [PMID: 20723179 DOI: 10.1111/j.1432-2277.2010.01143.x] [Cited by in Crossref: 92] [Cited by in F6Publishing: 75] [Article Influence: 8.4] [Reference Citation Analysis]
222 Massoud O, Heimbach J, Viker K, Krishnan A, Poterucha J, Sanchez W, Watt K, Wiesner R, Charlton M. Noninvasive diagnosis of acute cellular rejection in liver transplant recipients: a proteomic signature validated by enzyme-linked immunosorbent assay. Liver Transpl 2011;17:723-32. [PMID: 21618694 DOI: 10.1002/lt.22266] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
223 Bramhall S, Minford E, Gunson B, Buckels J. Liver transplantation in the UK. World J Gastroenterol 2001; 7(5): 602-611 [PMID: 11819840 DOI: 10.3748/wjg.v7.i5.602] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.1] [Reference Citation Analysis]
224 Sandrasegaran K, Ramaswamy R, Ghosh S, Tahir B, Akisik FM, Saxena R, Kwo P. Diffusion-weighted MRI of the transplanted liver. Clin Radiol. 2011;66:820-825. [PMID: 21621199 DOI: 10.1016/j.crad.2010.12.020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
225 Egawa H, Sakisaka S, Teramukai S, Sakabayashi S, Yamamoto M, Umeshita K, Uemoto S. Long-Term Outcomes of Living-Donor Liver Transplantation for Primary Biliary Cirrhosis: A Japanese Multicenter Study. Am J Transplant. 2016;16:1248-1257. [PMID: 26731039 DOI: 10.1111/ajt.13583] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]
226 Briest W. Do we have a new early marker of chronic transplant dysfunction now? Cardiovasc Res 2002;54:492-4. [PMID: 12031693 DOI: 10.1016/s0008-6363(02)00396-6] [Reference Citation Analysis]
227 Fairfield C, Penninga L, Powell J, Harrison EM, Wigmore SJ. Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients. Cochrane Database Syst Rev. 2015;CD007606. [PMID: 26666504 DOI: 10.1002/14651858.cd007606.pub3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
228 Gupta P, Hart J, Cronin D, Kelly S, Michael Millis J, Brady L. RISK FACTORS FOR CHRONIC REJECTION AFTER PEDIATRIC LIVER TRANSPLANTATION: . Transplantation 2001;72:1098-102. [DOI: 10.1097/00007890-200109270-00020] [Cited by in Crossref: 76] [Cited by in F6Publishing: 61] [Article Influence: 3.6] [Reference Citation Analysis]
229 Benjamin MM, Dasher KJ, Trotter JF. A comparison of outcomes between OKT3 and antithymocyte globulin for treatment of steroid-resistant rejection in hepatitis C liver transplant recipients. Transplantation 2014;97:470-3. [PMID: 24142032 DOI: 10.1097/01.TP.0000435701.54019.98] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
230 Abraham SC, Poterucha JJ, Rosen CB, Demetris AJ, Krasinskas AM. Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests. Am J Surg Pathol. 2008;32:965-973. [PMID: 18460980 DOI: 10.1097/pas.0b013e3181622490] [Cited by in Crossref: 50] [Cited by in F6Publishing: 6] [Article Influence: 3.6] [Reference Citation Analysis]
231 Koo J, Wang HL. Acute, Chronic, and Humoral Rejection. Surgical Pathology Clinics 2018;11:431-52. [DOI: 10.1016/j.path.2018.02.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
232 Xiong XF, Chen DD, Zhu HJ, Ge WH. Prognostic value of endogenous and exogenous metabolites in liver transplantation. Biomark Med 2020;14:1165-81. [PMID: 32969246 DOI: 10.2217/bmm-2020-0073] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
233 Lefkowitch JH. Diagnostic issues in liver transplantation pathology. Clinics in Liver Disease 2002;6:555-70. [DOI: 10.1016/s1089-3261(02)00003-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
234 Jain A, Mazariegos G, Pokharna R, Parizhskaya M, Kashyap R, Kosmach-park B, Smith A, Fung JJ, Reyes J. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis1. Transplantation 2003;75:1020-5. [DOI: 10.1097/01.tp.0000056168.79903.20] [Cited by in Crossref: 33] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
235 Sakamoto S, Haga H, Egawa H, Kasahara M, Ogawa K, Takada Y, Uemoto S. Living donor liver transplantation for acute liver failure in infants: The impact of unknown etiology. Pediatric Transplantation 2008;12:167-73. [DOI: 10.1111/j.1399-3046.2007.00718.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
236 Chen L, Himmelfarb EA, Sun M, Choi EK, Fan L, Lai J, Kim CJ, Xu H, Wang HL. Immunostaining Patterns of Posttransplant Liver Biopsies Using 2 Anti-C4d Antibodies. Appl Immunohistochem Mol Morphol 2020;28:146-53. [PMID: 32044883 DOI: 10.1097/PAI.0000000000000723] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
237 Duarte-Rojo A, Veldt BJ, Goldstein DD, Tillman HL, Watt KD, Heimbach JK, McHutchison JG, Poterucha JJ, Vargas-Vorackova F, Charlton MR. The course of posttransplant hepatitis C infection: comparative impact of donor and recipient source of the favorable IL28B genotype and other variables. Transplantation. 2012;94:197-203. [PMID: 22766768 DOI: 10.1097/tp.0b013e3182547551] [Cited by in Crossref: 41] [Cited by in F6Publishing: 18] [Article Influence: 4.1] [Reference Citation Analysis]
238 Nacif LS, David AI, Pinheiro RS, Diniz MA, Andraus W, Cruz RJ Jr, D'Albuquerque LA. An analysis of tacrolimus-related complications in the first 30 days after liver transplantation. Clinics (Sao Paulo) 2014;69:745-9. [PMID: 25518032 DOI: 10.6061/clinics/2014(11)07] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
239 Karam V, Sebagh M, Rifai K, Yilmaz F, Bhangui P, Danet C, Saliba F, Samuel D, Castaing D, Adam R, Feray C. Quality of life 10 years after liver transplantation: The impact of graft histology. World J Transplant 2016; 6(4): 703-711 [PMID: 28058221 DOI: 10.5500/wjt.v6.i4.703] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
240 Debette-gratien M, Woillard J, Picard N, Sebagh M, Loustaud-ratti V, Sautereau D, Samuel D, Marquet P. Influence of Donor and Recipient CYP3A4, CYP3A5, and ABCB1 Genotypes on Clinical Outcomes and Nephrotoxicity in Liver Transplant Recipients. Transplantation 2016;100:2129-37. [DOI: 10.1097/tp.0000000000001394] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 2.8] [Reference Citation Analysis]
241 Demetris A, Nalesnik M, Randhawa P, Wu T, Minervini M, Lai C, Lu Z. Histological Patterns of Rejection and Other Causes of Liver Dysfunction. Transplantation of the Liver. Elsevier; 2005. pp. 1057-128. [DOI: 10.1016/b978-0-7216-0118-2.50074-4] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
242 Puustinen L, Boyd S, Arkkila P, Isoniemi H, Arola J, Färkkilä M. Histologic surveillance after liver transplantation due to autoimmune hepatitis. Clin Transplant 2017;31:e12936. [DOI: 10.1111/ctr.12936] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
243 Li H, Xie H, Zhou L, Feng X, Wang W, Liang T, Zhang M, Zheng S. Copy number variation in CCL3L1 gene is associated with susceptibility to acute rejection in patients after liver transplantation: CNV in CCL3L1 gene and transplant rejection. Clinical Transplantation 2012;26:314-21. [DOI: 10.1111/j.1399-0012.2011.01486.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
244 Sim JH, Moon YJ, Kim SH, Kim KS, Lee JS, Song JG, Hwang GS. Association between Neutrophil-Lymphocyte Ratio and Herpes Zoster Infection in 1688 Living Donor Liver Transplantation Recipients at a Large Single Center. Biomedicines 2021;9:963. [PMID: 34440167 DOI: 10.3390/biomedicines9080963] [Reference Citation Analysis]
245 Bonhomme-Faivre L, Picard V, Saliba F, Abbara C, Fodil M, Chaunoy M, Farinotti R. Effect of the ABCB1 3435C>T polymorphism on tacrolimus concentrations and dosage requirements in liver transplant recipients. Am J Health Syst Pharm 2009;66:1645-51. [PMID: 19729569 DOI: 10.2146/ajhp080396] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
246 Charlton M, Levitsky J, Aqel B, OʼGrady J, Hemibach J, Rinella M, Fung J, Ghabril M, Thomason R, Burra P, Little EC, Berenguer M, Shaked A, Trotter J, Roberts J, Rodriguez-Davalos M, Rela M, Pomfret E, Heyrend C, Gallegos-Orozco J, Saliba F. International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients. Transplantation 2018;102:727-43. [PMID: 29485508 DOI: 10.1097/TP.0000000000002147] [Cited by in Crossref: 61] [Cited by in F6Publishing: 22] [Article Influence: 20.3] [Reference Citation Analysis]
247 Mizuguchi Y, Specht S, Isse K, Lunz JG, Demetris AJ. Biliary Epithelial Cells. In: Monga SPS, editor. Molecular Pathology of Liver Diseases. Boston: Springer US; 2011. pp. 27-51. [DOI: 10.1007/978-1-4419-7107-4_4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
248 Spada M, Riva S, Maggiore G, Cintorino D, Gridelli B. Pediatric liver transplantation. World J Gastroenterol 2009; 15(6): 648-674 [PMID: 19222089 DOI: 10.3748/wjg.15.648] [Cited by in CrossRef: 106] [Cited by in F6Publishing: 67] [Article Influence: 8.2] [Reference Citation Analysis]
249 Xu M, Tan C, Hu J, Alwahsh SM, Yan J, Hu J, Dai Z, Wang Z, Zhou J, Fan J, Huang X. Expression of hemopexin in acute rejection of rat liver allograft identified by serum proteomic analysis. Shock 2014;42:65-74. [PMID: 24667618 DOI: 10.1097/SHK.0000000000000171] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
250 van den Heuvel MC, Gouw AS, Boot M, Slooff MJ, Poppema S, de Jong KP. The finest branches of the biliary tree might induce biliary vascularization necessary for biliary regeneration. J Hepatol 2006;44:947-55. [PMID: 16310280 DOI: 10.1016/j.jhep.2005.08.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
251 Ueno T, Tanaka N, Ihara Y, Takama Y, Yamada H, Mushiake S, Fukuzawa M. Graft fibrosis in patients with biliary atresia after pediatric living-related liver transplantation. Pediatr Transplant. 2011;15:470-475. [PMID: 21771230 DOI: 10.1111/j.1399-3046.2011.01483.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
252 Weiler N, Thrun I, Hoppe-lotichius M, Zimmermann T, Kraemer I, Otto G. Early Steroid-Free Immunosuppression With FK506 After Liver Transplantation: Long-Term Results of a Prospectively Randomized Double-Blinded Trial. Transplantation 2010;90:1562-6. [DOI: 10.1097/tp.0b013e3181ff8794] [Cited by in Crossref: 39] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
253 McCabe M, Rush N, Lammert C, Patidar KR, Nephew L, Saxena R, Ekser B, Salven J, Kubal C, Ghabril M. HLA-DR Mismatch and Black Race Are Associated With Recurrent Autoimmune Hepatitis After Liver Transplantation. Transplant Direct 2021;7:e714. [PMID: 34131586 DOI: 10.1097/TXD.0000000000001160] [Reference Citation Analysis]
254 Dickson RC, Pungpapong S, Keaveny AP, Taner CB, Ghabril M, Aranda-michel J, Satyanarayana R, Bonatti H, Kramer DJ, Nguyen JH. Improving graft survival for patients undergoing liver transplantation: Improving graft survival. Clinical Transplantation 2011;25:E345-55. [DOI: 10.1111/j.1399-0012.2011.01428.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
255 Banff Working Group on Liver Allograft Pathology. Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational tolerance. Liver Transpl. 2012;18:1154-1170. [PMID: 22645090 DOI: 10.1002/lt.23481] [Cited by in Crossref: 78] [Cited by in F6Publishing: 63] [Article Influence: 8.7] [Reference Citation Analysis]
256 Thomson AW, Vionnet J, Sanchez-Fueyo A. Understanding, predicting and achieving liver transplant tolerance: from bench to bedside. Nat Rev Gastroenterol Hepatol 2020;17:719-39. [PMID: 32759983 DOI: 10.1038/s41575-020-0334-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
257 Wyatt JI. Liver transplant pathology - messages for the non-specialist. Histopathology 2010;57:333-41. [PMID: 20695921 DOI: 10.1111/j.1365-2559.2010.03598.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
258 Del Bello A, Congy-Jolivet N, Danjoux M, Muscari F, Lavayssière L, Esposito L, Cardeau-Desangles I, Guitard J, Dörr G, Milongo D, Suc B, Duffas JP, Alric L, Bureau C, Guilbeau-Frugier C, Rostaing L, Kamar N. De novo donor-specific anti-HLA antibodies mediated rejection in liver-transplant patients. Transpl Int. 2015;28:1371-1382. [PMID: 26303035 DOI: 10.1111/tri.12654] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 9.0] [Reference Citation Analysis]
259 Warlé MC, Metselaar HJ, Hop WC, Gyssens IC, Kap M, Kwekkeboom J, de Rave S, Zondervan PE, Ijzermans JN, Tilanus HW, Bouma GJ. Early differentiation between rejection and infection in liver transplant patients by serum and biliary cytokine patterns: . Transplantation 2003;75:146-51. [DOI: 10.1097/00007890-200301150-00026] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
260 Verhelst XP, Troisi RI, Colle I, Geerts A, van Vlierberghe H. Biomarkers for the diagnosis of acute cellular rejection in liver transplant recipients: A review. Hepatol Res. 2013;43:165-178. [PMID: 23186289 DOI: 10.1111/hepr.12012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
261 Tambur AR, Ben-ari Z, Herrera ND, Klein T, Michowiz R, Mor E. Donor-specific hyporesponsiveness in ELISPOT assay is associated with early recurrence of hepatitis C in liver transplant recipients. Human Immunology 2005;66:21-7. [DOI: 10.1016/j.humimm.2004.08.180] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
262 Beckebaum S, Iacob S, Sweid D, Sotiropoulos GC, Saner F, Kaiser G, Radtke A, Klein CG, Erim Y, de Geest S, Paul A, Gerken G, Cicinnati VR. Efficacy, safety, and immunosuppressant adherence in stable liver transplant patients converted from a twice-daily tacrolimus-based regimen to once-daily tacrolimus extended-release formulation. Transpl Int. 2011;24:666-675. [PMID: 21466596 DOI: 10.1111/j.1432-2277.2011.01254.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 73] [Article Influence: 7.6] [Reference Citation Analysis]
263 Caston JJ, Castells L, Varo E, Gomez MA, de la Mata M, Campos-Varela I, Lumbreras C, Gonzalez-Dieguez L, Fabregat J, Herrero I, Salcedo M, Sanchez-Antolín G, Torre-Cisneros J. Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation. Transplantation 2016;100:593-9. [PMID: 26371595 DOI: 10.1097/TP.0000000000000912] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
264 Ahmad J. Recurrent hepatitis C after liver transplantation: A nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin. Liver Transplantation 2001;7:863-9. [DOI: 10.1053/jlts.2001.27869] [Cited by in Crossref: 88] [Cited by in F6Publishing: 73] [Article Influence: 4.2] [Reference Citation Analysis]
265 Sohn AJ, Jeon H, Ahn J. Primary care of the liver transplant recipient. Prim Care. 2011;38:499-514; ix. [PMID: 21872094 DOI: 10.1016/j.pop.2011.05.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
266 Neil DA, Hubscher SG. Delay in diagnosis: a factor in the poor outcome of late acute rejection of liver allografts. Transplant Proc 2001;33:1525-6. [PMID: 11267407 DOI: 10.1016/s0041-1345(00)02582-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
267 Bellizzi AM, LeGallo RD, Boyd JC, Iezzoni JC. Hepatocyte cytokeratin 7 expression in chronic allograft rejection. Am J Clin Pathol. 2011;135:238-244. [PMID: 21228364 DOI: 10.1309/ajcpnrxcap92knoj] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
268 Jain A, Demetris AJ, Kashyap R, Blakomer K, Ruppert K, Khan A, Rohal S, Starzl TE, Fung JJ. Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years. Liver Transpl. 2001;7:623-630. [PMID: 11460230 DOI: 10.1053/jlts.2001.25364] [Cited by in Crossref: 63] [Cited by in F6Publishing: 46] [Article Influence: 3.0] [Reference Citation Analysis]
269 Isse K, Grama K, Abbott IM, Lesniak A, Lunz JG, Lee WM, Specht S, Corbitt N, Mizuguchi Y, Roysam B, Demetris AJ. Adding value to liver (and allograft) biopsy evaluation using a combination of multiplex quantum dot immunostaining, high-resolution whole-slide digital imaging, and automated image analysis. Clin Liver Dis 2010;14:669-85. [PMID: 21055689 DOI: 10.1016/j.cld.2010.07.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
270 Sugawara Y. Positive T lymphocytotoxic cross-match in living donor liver transplantation. Liver Transplantation 2003;9:1062-6. [DOI: 10.1053/jlts.2003.50209] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
271 Fairfield C, Penninga L, Powell J, Harrison EM, Wigmore S, Fairfield C. Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd007606.pub2] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
272 Demetris AJ, Bellamy C, Hübscher SG, O’Leary J, Randhawa PS, Feng S, Neil D, Colvin RB, McCaughan G, Fung JJ. 2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection. Am J Transplant. 2016; Epub ahead of print. [PMID: 27273869 DOI: 10.1111/ajt.13909] [Cited by in Crossref: 230] [Cited by in F6Publishing: 187] [Article Influence: 38.3] [Reference Citation Analysis]
273 Bosch W, Heckman MG, Pungpapong S, Diehl NN, Shalev JA, Hellinger WC. Association of cytomegalovirus infection and disease with recurrent hepatitis C after liver transplantation. Transplantation. 2012;93:723-728. [PMID: 22406819 DOI: 10.1097/tp.0b013e3182472876] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 2.9] [Reference Citation Analysis]
274 Lim KB, Sima HR, Fiel MI, Khaitova V, Doucette JT, Chernyiak M, Ahmad J, Bach N, Chang C, Grewal P, Kim-Schluger L, Liu L, Odin J, Perumalswami P, Florman SS, Schiano TD. Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virus. World J Gastroenterol 2015; 21(20): 6236-6245 [PMID: 26034358 DOI: 10.3748/wjg.v21.i20.6236] [Reference Citation Analysis]
275 Aini W, Miyagawa-Hayashino A, Ozeki M, Tsuruyama T, Tamaki K, Uemoto S, Haga H. Frequent hepatocyte chimerism in long-term human liver allografts independent of graft outcome. Transpl Immunol. 2013;28:100-105. [PMID: 23268137 DOI: 10.1016/j.trim.2012.12.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
276 Khalifa A, Lewin DN, Sasso R, Rockey DC. The Utility of Liver Biopsy in the Evaluation of Liver Disease and Abnormal Liver Function Tests. Am J Clin Pathol 2021;156:259-67. [PMID: 33693456 DOI: 10.1093/ajcp/aqaa225] [Reference Citation Analysis]
277 Del Bello A, Gaible C, Longlune N, Hebral AL, Esposito L, Gandia P, Kamar N. Tacrolimus Intrapatient Variability After Switching From Immediate or Prolonged-Release to Extended-Release Formulation, After an Organ Transplantation. Front Pharmacol 2021;12:602764. [PMID: 34690747 DOI: 10.3389/fphar.2021.602764] [Reference Citation Analysis]
278 Shulman HM, Mcdonald GB. Hepatic Complications of Hematopoietic Cell Transplantation. In: Gershwin ME, Vierling JM, Manns MP, editors. Liver Immunology. Totowa: Humana Press; 2007. pp. 409-21. [DOI: 10.1007/978-1-59745-518-3_32] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
279 van den Heuvel MC, de Jong KP, Boot M, Slooff MJH, Poppema S, Gouw ASH. Preservation of Bile Ductules Mitigates Bile Duct Loss. Am J Transplant 2006;6:2660-71. [DOI: 10.1111/j.1600-6143.2006.01511.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
280 Choudhary NS, Saigal S, Bansal RK, Saraf N, Gautam D, Soin AS. Acute and Chronic Rejection After Liver Transplantation: What A Clinician Needs to Know. J Clin Exp Hepatol 2017;7:358-66. [PMID: 29234201 DOI: 10.1016/j.jceh.2017.10.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]
281 Zhang Y, Li S, Wang G, Peng Y, Zhang Q, Li H, Zhang J, Wang G, Yi S, Chen X, Xiang AP, Yang Y, Chen G. Mesenchymal stem cells for treatment of steroid-resistant acute rejection after liver transplantation. Liver Research 2017;1:140-5. [DOI: 10.1016/j.livres.2017.07.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
282 Khettry U, Backer A, Ayata G, Lewis WD, Jenkins RL, Gordon FD. Centrilobular histopathologic changes in liver transplant biopsies. Hum Pathol. 2002;33:270-276. [PMID: 11979366 DOI: 10.1053/hupa.2002.32225] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
283 Tannuri AC, Lima F, Mello ES, Tanigawa RY, Tannuri U. Prognostic factors for the evolution and reversibility of chronic rejection in pediatric liver transplantation. Clinics (Sao Paulo) 2016;71:216-20. [PMID: 27166772 DOI: 10.6061/clinics/2016(04)07] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
284 Cassiman D, Libbrecht L, Sinelli N, Desmet V, Denef C, Roskams T. The vagal nerve stimulates activation of the hepatic progenitor cell compartment via muscarinic acetylcholine receptor type 3. Am J Pathol 2002;161:521-30. [PMID: 12163377 DOI: 10.1016/S0002-9440(10)64208-3] [Cited by in Crossref: 82] [Cited by in F6Publishing: 23] [Article Influence: 4.1] [Reference Citation Analysis]
285 Hillebrands J, van den Hurk BM, Klatter FA, Popa ER, Nieuwenhuis P, Rozing J. Recipient origin of neointimal vascular smooth muscle cells in cardiac allografts with transplant arteriosclerosis. J Heart Lung Transplant 2000;19:1183-92. [PMID: 11124488 DOI: 10.1016/s1053-2498(00)00209-6] [Cited by in Crossref: 44] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
286 Clouston AD, Jonsson JR, Balderson GA, Fawcett J, Lynch SV, Kelso A, Powell EE. Lymphocyte apoptosis and cell replacement in human liver allografts. Transplantation. 2002;73:1828-1834. [PMID: 12085009 DOI: 10.1097/00007890-200206150-00022] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
287 Maki H, Kaneko J, Arita J, Akamatsu N, Sakamoto Y, Hasegawa K, Tamura S, Takao H, Shibata E, Kokudo N. Proximal total splenic artery embolization for refractory hepatic encephalopathy. Clin J Gastroenterol 2018;11:156-60. [PMID: 29196972 DOI: 10.1007/s12328-017-0805-5] [Reference Citation Analysis]
288 Ran CF, Dou K, Liang Z, Liu Y, Li K. Changes in the expression of endothelial-overexpressed lipopolysaccharide-associated factor 1 in grafts during acute rejection following liver transplantation in rats. J Int Med Res 2008;36:460-6. [PMID: 18534126 DOI: 10.1177/147323000803600309] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
289 Kogiso T, Egawa H, Teramukai S, Taniai M, Hashimoto E, Tokushige K, Sakisaka S, Sakabayashi S, Yamamoto M, Umeshita K, Uemoto S. Risk factors for recurrence of primary biliary cholangitis after liver transplantation in female patients: A Japanese multicenter retrospective study. Hepatol Commun 2017;1:394-405. [PMID: 29404468 DOI: 10.1002/hep4.1037] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
290 Vogel A, Heinrich E, Bahr MJ, Rifai K, Flemming P, Melter M, Klempnauer J, Nashan B, Manns MP, Strassburg CP. Long-term outcome of liver transplantation for autoimmune hepatitis. Clin Transplant. 2004;18:62-69. [PMID: 15108772 DOI: 10.1111/j.1399-0012.2004.00117.x] [Cited by in Crossref: 102] [Cited by in F6Publishing: 74] [Article Influence: 5.7] [Reference Citation Analysis]
291 Marseglia A, Ginammi M, Bosisio M, Stroppa P, Colledan M, D'Antiga L. Determinants of large drain losses early after pediatric liver transplantation. Pediatr Transplant 2017;21. [PMID: 28417522 DOI: 10.1111/petr.12932] [Cited by in Crossref: 5] [Article Influence: 1.0] [Reference Citation Analysis]
292 Vivarelli M, Benedetti Cacciaguerra A, Lerut J, Lanari J, Conte G, Pravisani R, Lambrechts J, Iesari S, Ackenine K, Nicolini D, Cillo U, Zanus G, Colledan M, Risaliti A, Baccarani U, Rogiers X, Troisi RI, Montalti R, Mocchegiani F. Infrarenal versus supraceliac aorto-hepatic arterial revascularisation in adult liver transplantation: multicentre retrospective study. Updates Surg 2020;72:659-69. [PMID: 32594369 DOI: 10.1007/s13304-020-00839-x] [Reference Citation Analysis]
293 Rifai K, Sebagh M, Karam V, Saliba F, Azoulay D, Adam R, Castaing D, Bismuth H, Reynès M, Samuel D, Féray C. Donor age influences 10-year liver graft histology independently of hepatitis C virus infection. Journal of Hepatology 2004;41:446-53. [DOI: 10.1016/j.jhep.2004.05.013] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 2.8] [Reference Citation Analysis]
294 Petrovic LM. Can early liver biopsies predict long-term outcome of the graft? Liver Transpl 2003;9:99-100. [DOI: 10.1002/lt.500090116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
295 Stravitz RT, Shiffman ML, Sanyal AJ, Luketic VA, Sterling RK, Heuman DM, Ashworth A, Mills AS, Contos M, Cotterell AH, Maluf D, Posner MP, Fisher RA. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation. Liver Transpl 2004;10:850-8. [DOI: 10.1002/lt.20189] [Cited by in Crossref: 117] [Cited by in F6Publishing: 95] [Article Influence: 6.5] [Reference Citation Analysis]
296 Idilman R, Erden E, Kuzu I, Ersoz S, Karasu Z, Karayalcin K, Yuce G, Tokat Y, Şahin Y, Tukun A, Akarca US, Karayalcin S. Recipient-Derived Hepatocytes in Sex-Mismatched Liver Allografts after Liver Transplantation: Early versus Late Transplant Biopsies. Transplantation 2004;78:1647-52. [DOI: 10.1097/01.tp.0000144055.78462.4f] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
297 Neil DA, Hubscher SG. Histologic and biochemical changes during the evolution of chronic rejection of liver allografts. Hepatology. 2002;35:639-651. [PMID: 11870379 DOI: 10.1053/jhep.2002.31726] [Cited by in Crossref: 69] [Cited by in F6Publishing: 55] [Article Influence: 3.5] [Reference Citation Analysis]
298 Fernández I, Ulloa E, Colina F, Abradelo M, Jiménez C, Gimeno A, Meneu JC, Lumbreras C, Solís-Herruzo JA, Moreno E. Incidence, risk factors, and outcome of chronic rejection during antiviral therapy for posttransplant recurrent hepatitis C. Liver Transpl. 2009;15:948-955. [PMID: 19642125 DOI: 10.1002/lt.21780] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
299 Uryuhara K, Ambiru S, Dehoux JP, Oike F, Talpe S, Gianello P. Thymectomy impairs but does not uniformly abrogate long-term acceptance of semi-identical liver allograft in inbred miniature Swine temporarily treated with FK506. Transplantation 2004;77:1172-80. [PMID: 15114080 DOI: 10.1097/01.tp.0000121762.47432.15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
300 Czaja AJ. Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation. Dig Dis Sci. 2012;57:2248-2266. [PMID: 22562533 DOI: 10.1007/s10620-012-2179-3] [Cited by in Crossref: 65] [Cited by in F6Publishing: 55] [Article Influence: 6.5] [Reference Citation Analysis]
301 Spada M, Petz W, Bertani A, Riva S, Sonzogni A, Giovannelli M, Torri E, Torre G, Colledan M, Gridelli B. Randomized trial of basiliximab induction versus steroid therapy in pediatric liver allograft recipients under tacrolimus immunosuppression. Am J Transplant 2006;6:1913-21. [PMID: 16771811 DOI: 10.1111/j.1600-6143.2006.01406.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
302 Höroldt BS, Burattin M, Gunson BK, Bramhall SR, Nightingale P, Hübscher SG, Neuberger JM. Does the Banff rejection activity index predict outcome in patients with early acute cellular rejection following liver transplantation? Liver Transpl. 2006;12:1144-1151. [PMID: 16799959 DOI: 10.1002/lt.20779] [Cited by in Crossref: 45] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
303 Kanodia KV, Vanikar AV, Modi PR, Patel RD, Suthar KS, Nigam LK, Trivedi HL. Histological and Clinicopathological Evaluation of Liver Allograft Biopsy: An Initial Experience of Fifty Six Biopsies. J Clin Diagn Res 2015;9:EC17-20. [PMID: 26673862 DOI: 10.7860/JCDR/2015/13664.6812] [Reference Citation Analysis]
304 Irlès‐depé M, Roullet S, Neau‐cransac M, Dumortier J, Dharancy S, Houssel‐debry P, Boillot O, Chiche L, Laurent C, Laharie D, De Lédinghen V. Impact of Preexisting Inflammatory Bowel Disease on the Outcome of Liver Transplantation for Primary Sclerosing Cholangitis. Liver Transpl 2020;26:1477-91. [DOI: 10.1002/lt.25838] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
305 Yilmaz F, Aydin U, Nart D, Zeytunlu M, Karasu Z, Kaya T, Ozer I, Yuce G, Aydogdu S, Kilic M. The incidence and management of acute and chronic rejection after living donor liver transplantation. Transplant Proc 2006;38:1435-7. [PMID: 16797325 DOI: 10.1016/j.transproceed.2006.02.108] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
306 Sheikh-ali M, Keaveny AP, Chamseddin A, Aguirre L, Clarke B, Meek S. 25-Hydroxyvitamin D Levels and Acute Cellular Rejection in Liver Transplant Patients. Endocrine Practice 2014;20:769-74. [DOI: 10.4158/ep13226.or] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
307 Weiner C, Weintraub L, Wistinghausen B, Tomaino J, Arnon R, Kerkar N, Miloh T. Graft rejection in pediatric liver transplant patients with Epstein-Barr viremia and post-transplant lymphoproliferative disease. Pediatr Transplant 2012;16:458-64. [PMID: 22554096 DOI: 10.1111/j.1399-3046.2012.01713.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
308 Gopal PB, Kapoor D, Raya R, Subrahmanyam M, Juneja D, Sukanya B. Critical care issues in adult liver transplantation. Indian J Crit Care Med 2009;13:113-9. [PMID: 20040807 DOI: 10.4103/0972-5229.58535] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
309 Fischer RT, Day JC, Wasserkrug H, Faseler M, Kats A, Daniel JF, Slowik V, Andrews W, Hendrickson RJ. Complications of Cryptosporidium infection after pediatric liver transplantation: Diarrhea, rejection, and biliary disease. Pediatr Transplant 2020;24:e13807. [PMID: 32777150 DOI: 10.1111/petr.13807] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
310 Oh SH, Jeong IS, Kim DY, Namgoong JM, Jhang WK, Park SJ, Jung DH, Moon DB, Song GW, Park GC, Ha TY, Ahn CS, Kim KH, Hwang S, Lee SG, Kim KM. Recent Improvement in Survival Outcomes and Reappraisal of Prognostic Factors in Pediatric Living Donor Liver Transplantation. Liver Transpl 2021. [PMID: 34536963 DOI: 10.1002/lt.26308] [Reference Citation Analysis]
311 Riva S, Sonzogni A, Bravi M, Bertani A, Alessio MG, Candusso M, Stroppa P, Melzi ML, Spada M, Gridelli B. Late graft dysfunction and autoantibodies after liver transplantation in children: preliminary results of an Italian experience. Liver Transpl. 2006;12:573-577. [PMID: 16555335 DOI: 10.1002/lt.20673] [Cited by in Crossref: 50] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
312 Hashimoto E, Taniai M, Yatsuji S, Tokushige K, Shiratori K, Yamamoto M, Fuchinoue S. Long-term clinical outcome of living-donor liver transplantation for primary biliary cirrhosis. Hepatology Research 2007;37:S455-61. [DOI: 10.1111/j.1872-034x.2007.00246.x] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
313 Neil DA, Hubscher SG. Are parenchymal changes in early post-transplant biopsies related to preservation-reperfusion injury or rejection. Transplantation. 2001;71:1566-1572. [PMID: 11435966 DOI: 10.1097/00007890-200106150-00014] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 2.5] [Reference Citation Analysis]
314 García-Reyne A, Lumbreras C, Fernández I, Colina F, Abradelo M, Magan P, San-Juan R, Manrique A, López-Medrano F, Fuertes A. Influence of antiviral therapy in the long-term outcome of recurrent hepatitis C virus infection following liver transplantation. Transpl Infect Dis. 2013;15:405-415. [PMID: 23725370 DOI: 10.1111/tid.12097] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
315 Guzman G. Overview of liver pathology. Dis Mon 2008;54:419-31. [PMID: 18570912 DOI: 10.1016/j.disamonth.2008.03.007] [Reference Citation Analysis]
316 Cole CR, Bucuvalas JC, Hornung R, Ryckman FC, Alonso MP, Balistreri WF, Kotagal U. Outcome after pediatric liver transplantation impact of living donor transplantation on cost. J Pediatr 2004;144:729-35. [PMID: 15192617 DOI: 10.1016/j.jpeds.2004.03.032] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
317 Jain A, Kashyap R, Demetris AJ, Eghstesad B, Pokharna R, Fung JJ. A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C. Liver Transpl. 2002;8:40-46. [PMID: 11799484 DOI: 10.1053/jlts.2002.29763] [Cited by in Crossref: 113] [Cited by in F6Publishing: 101] [Article Influence: 5.7] [Reference Citation Analysis]
318 Haugk B, El-refaie A, Burt AD. Pathology of liver transplantation. Current Diagnostic Pathology 2007;13:75-84. [DOI: 10.1016/j.cdip.2006.11.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
319 Sebagh M. All liver recipients benefit from the protocol 10-year liver biopsies. Hepatology 2003;37:1293-301. [DOI: 10.1053/jhep.2003.50231] [Cited by in Crossref: 96] [Cited by in F6Publishing: 79] [Article Influence: 5.1] [Reference Citation Analysis]
320 Quintero J, Juampérez J, Ortega J, Molino JA, Castells L, Bilbao I, Rodrigo C, Charco R. Conversion from twice-daily to once-daily tacrolimus formulation in pediatric liver transplant recipients - a long-term prospective study. Transpl Int 2018;31:38-44. [DOI: 10.1111/tri.13037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]